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“The brain asks the questions, 
the heart has the answers”
6
ABSTRACT
Electrocardiography (ECG) is a routine diagnostic method for all young 
ischemic stroke (IS) patients, although the relevance of its findings is as yet 
poorly known. A diagnostic work-up to reveal etiology in a young IS patient 
includes many cardiac diagnostic methods, as finding a high-risk source of 
cardioembolism (HRCE) will influence the secondary prevention after IS, 
and also provides a marker for high risk of recurrent events and mortality. IS 
per se is a disastrous event, and recurrent cardiovascular events may wors-
en the situation further. Identifying patients at a high risk of recurrent events 
is therefore important.
The Helsinki Young Stroke Registry (HYSR) includes all 15- to 49-year-
old IS patients treated at the Helsinki University Hospital between 1994 
and 2007. Blinded to other current clinical data, we analyzed 12-lead resting 
ECGs obtained 1 to 14 days after IS in 690 patients. We used logistic regres-
sion, adjusted for demographic and clinical confounders, to investigate, in 
78 patients, what ECG findings are related to an etiology of HRCE (Study 
I). We investigated what ECG findings bear an increased risk of new cardio-
vascular events (Study II) and mortality (Study III), using Cox regression ad-
justed for demographic confounders and comorbidities. We also collected 
a cohort of stroke-free control subjects in order to study the association of 
ECG markers with IS at young age, with stratified analysis according to IS 
subtype (Study IV).
Of our IS patient cohort (median age 41 years, 63% male), 35% showed 
some ECG abnormality. The most common abnormalities were T-wave in-
versions (16%), left ventricular hypertrophy (LVH) (14%), prolonged P-waves 
(13%), and prolonged corrected QT interval (QTc) (12%). Of all IS patients, 
3% had atrial fibrillation (AF), and 4% P-terminal force in lead V1 (PTF). A 
longer QRS complex duration, a longer QTc, and wider QRS-T-angle were 
independently associated with HRCE. Interestingly, PTF had the strongest 
independent association with HRCE (hazard ratio 43.18). After a median 
follow-up of 8.8 years, 26.4% of patients experienced some cardiovascular 
event. 14.6% suffered a recurrent stroke, and 16.1% died; 9.1% died from car-
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ECG parameters associated with recurrent cardiovascular events were 
bundle branch blocks, PTF, LVH, and a broader QRS complex. No ECG pa-
rameter was associated with stroke recurrence. A higher heart rate, a short-
er P-wave and longer QTc were associated with increased all-cause mortal-
ity. Only a higher heart rate was associated with death from cardiovascular 
causes. In the case-control study, abnormal P-waves, PTF, interatrial block 
– and combinations of these P-wave abnormalities with LVH – were associ-
ated with cardioembolic IS. Abnormal P-wave and IAB were also associat-
ed with cryptogenic IS; and LVH was associated with small-vessel disease 
(SVD) subtype.
In conclusion, ECG in young IS patients provides information on IS etiol-
ogy, risk of recurrent events, and mortality. P-wave abnormalities and ECG 
markers of LVH are more frequent in young IS patients than in stroke-free 
controls, suggesting they may be markers of increased IS risk, which is most-
ly explained by the HRCE subgroup.
Keywords:
Case-control studies; Electrocardiography; Embolic stroke; Follow-up studies; 
Hypertrophy, Left Ventricular; Stroke
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Abbreviations
AF  Atrial fibrillation
ApoA-I Apolipoprotein A I
AV-block Atrioventricular block
BMI  Body mass index
BNP  Brain natriuretic peptide
CE  Cardioembolism
CI  Confidence interval
CRP  C-reactive protein
CT  Computed tomography
ECG  Electrocardiogram
ESUS Embolic stroke of undetermined source
HDL  High density lipoprotein
HRCE High-risk source of cardioembolism
HYSR Helsinki Young Stroke Registry
ICD  Implantable cardioverter-defibrillator
IS  Ischemic stroke
IVCD  Intraventricular conduction delay
LA  Left atrium
LAA  Large artery atherosclerosis
LAVI  Left atrial volume index
LBBB Left bundle branch block
LRCE Low-risk source of cardioembolism
LVH  Left ventricular hypertrophy
MRI  Magnetic resonance imaging
NIHSS National Institutes of Health Stroke Scale
PFO  Patent foramen ovale
PTF  P-terminal force
QTc  Corrected QT interval
RBBB Right bundle branch block
SVD  Small-vessel disease
T1D  Type 1 diabetes mellitus
T2D  Type 2 diabetes mellitus
TEE  Transesophageal echocardiography
TIA  Transient ischemic attack
TOAST Trial of Org 10172 in Acute Stroke Treatment
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Ischemic stroke (IS) in the young is considered to be a different disease than 
in the elderly. Major differences include risk factor profiles and etiology, es-
pecially the large number of dissections and cryptogenic cases in young pa-
tients (Putaala et al. 2009, Yesilot Barlas et al. 2013). IS in young persons is a 
great socioeconomic burden, and recurrent cardiovascular events further di-
minish its morbidity and mortality, which are far higher than in a background 
population of the same age (Waje-Andreassen et al. 2007, Aarnio et al. 2014, 
Waje-Andreassen et al. 2014).
Among IS patients of all ages, cardioembolic strokes from high-risk sourc-
es (HRCE), are of special interest, due to their secondary prevention with 
anticoagulant therapy, which differs from prevention from other etiologies, 
and also of interest is their their poor prognosis (Kolominsky-Rabas et al. 
2001, Aarnio et al. 2014). There also exists a recently defined new etiologic 
group, ESUS (embolic stroke of undetermined source), in which clinical and 
neuroradiological signs point toward embolism, although without any certain 
embolic source found (Hart et al. 2014). Approximately half of these all young 
IS patients are estimated to fulfill the ESUS criteria (Ladeira et al. 2015).
The ECG in young IS is little studied. One small study on only young IS 
patients, has only 44 patients, too few for more detailed analysis (Hindfelt 
& Nilsson 1976). To the best of our knowledge, no large study has systemat-
ically analyzed ECG findings in young patients with IS. ECG abnormalities 
are common in older IS patients, in whom approximately two-thirds present 
with ECG abnormalities, with QT-prolongation, T-wave inversion, ST-seg-
ment depression, U-waves and atrial fibrillation (AF) being the most common 
(Goldstein et al. 1979, Christensen et al. 2005). Many ECG abnormalities are 
markers of diminished prognosis in the general population, although the 
prognostic value is far less studied in IS patients.
AF is a well-known risk factor for IS, although recently a theory of fibrous 
atrial cardiopathy has emerged, stating that AF is only part of a larger set 
of disease, in which unhealthy atrial substrate causes both thrombosis risk 
and AF rhythm (Wolf et al. 1978, Kamel et al. 2016). Certain other markers of 
atrial cardiopathy, interatrial blocks and P-terminal force on ECG, have also 
been linked to IS risk (Soliman et al. 2010, Kamel et al. 2014, O’Neal et al. 
2016). One study found interatrial block to be specifically linked to cardio-
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embolic IS (Lorbar et al. 2005). Moreover, LVH on ECG has been linked to 
increased risk of IS (Ishikawa et al. 2009). However, these studies mainly in-
volve IS patients of older age.
We aimed to assess what ECG abnormalities exist in young IS patients, and 
what is their association with IS etiology, event-free survival, and mortality, and 
whether ECG differences exist in young IS patients and in healthy controls, 
suggesting some ECG findings as being markers of increased IS risk.
2. REVIEW OF THE LITERATURE
2.1 The electrocardiogram
2.1.1 Definitions of electrocardiographic findings and abnormalities
The ECG, originally the string galvanometer, was introduced in 1902 by Willem 
Einthoven. He called the waves of the electrocardiogram P, Q, R, S, and T. The 
leads on the electrocardiogram represent components of the heart vector, show-
ing body surface potential differences between two or more sites (Kligfield et al. 
2007). The P wave reflects atrial depolarization, the Q, R, and S waves (QRS com-
plex) ventricular depolarization, and the T wave ventricular repolarization. Since 
introduction of the ECG, much research has concentrated on its diagnostic and 
prognostic value. The introduction of computers has also changed interpreta-
tion of the ECG; for example, the recommendation is that global assessment of 
conduction times should be interpreted by automatic algorithms (Kligfield et al. 
2007). Recommendations, based on research, on what to consider normal or 
abnormal on ECG appeared in publications by many heart organizations.
Heart rate is defined as number of heart beats (QRS-complexes) per min-
ute, although ECG recordings usually last only five seconds, so heart rate is 
calculated from the mean R-R intervals of this recording, i.e. the time between 
the QRS complexes. Heart rate is 60 divided by R-R interval length in seconds.
The normal heart rhythm is sinus rhythm, originating from a natural pace-
maker within the sinus node located in the upper part of the right atrium. The 
sinus node is under neurohumoral control, supplying the heart rate the body is 
requiring. Under normal circumstances, an electrical impulse generated by the 
sinus node spreads through the atria, creating an atrial depolarization and con-
traction (atrial activation), and then is conducted further to the ventricles, cre-
ating ventricular depolarization and contraction (ventricular activation) (Mac-
14
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farlane et al. 2011, p 146). AF is chaotic electrical activity in the atria, producing 
no coordinated atrial contraction, and spreading at variable intervals through 
the atrioventricular node to the ventricles, hence producing no P-waves on 
ECG and producing varying R-R intervals (Figure 1). AF can have a focal trig-
ger, or the atrial tissue can be damaged in larger areas of the atria, allowing 
chaotic conduction of electrical wavelets (Macfarlane et al. 2011, p. 1218).
P-wave duration is defined as the beginning of the deflection in the lead 
where it is first visible, to the end of the deflection where it is visible last. Cal-
culation of the P-wave axis is calculated based on its amplitude in the various 
leads of the ECG. A P-wave axis is normal between 0º and 90º (Macfarlane 
et al. 2011, p. 1196). Abnormalities of the P-wave reflect atrial dilatation, atrial 
muscular hypertrophy, elevated atrial pressure, impaired ventricular disten-
sibility, or delayed intra-atrial conduction. Criteria often used to electrocar-
diographically determine abnormalities of the left atrium include P-terminal 
force in V1 (PTF, terminal negative part ≥40 ms in duration and ≥1.0 mm in 
depth), prolonged P-wave duration beyond 110 ms, and leftward P-wave axis 
(Figure 2a-b) (Hazen et al. 1991, Hancock et al. 2009). A P-wave prolonged 
beyond 120 ms was, in a small study, found indicating decreased left atrial 
function, regarding stroke volume, ejection fraction, and produced kinetic 
energy (Goyal & Spodick 2001). Three degrees of interatrial block have been 
defined, thus: 1º only having a prolonged P-wave, 2º having P-wave variation 
between 1º and 3º morphology, whereas 3º interatrial block has a prolonged 
P-wave and negative-positive morphology in the inferior leads reflecting 
right atrial depolarization in a superior-to-inferior direction and left atrial de-
polarization in an inferior-to-superior direction (Figure 2c). However, some 
discrepancy exists in the definition of P-wave prolongation for interatrial 
blocks (Bayés de Luna et al. 2012, Chhabra et al. 2014). PTF serves relatively 
Figure 1. Atrial fibrillation. Note irregularity of rhythm and the lack of P-waves.
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well as a marker of left atrial dilatation, but it can be caused also by impaired 
interatrial conduction and especially of elevated left atrial pressure (Heikkilä 
et al. 1973, Platonov et al. 2012).
The PR-interval, also called the PQ-interval, is defined from the beginning 
of the P-wave deflection in any lead, to the beginning of the QRS-complex 
deflection in any lead. A PR-time of >200 ms is considered abnormal, and 
is also called a 1º atrioventricular block. A 2º atrioventricular block is de-
fined as a condition in which some of the P-waves are not conducted to the 
ventricles, either with lengthening of PR-interval before the non-conducted 
P-wave (Mobitz I or Wenckebach), or with a constant PR-interval (Mobitz II). 
In 3º atrioventricular block, none of the P-waves are conducted to the ventri-
cles, and ventricular activations are escape beats from a nodal or ventricular 
pacemaker (Macfarlane et al. 2011, pp 2164-5).
The duration of the QRS complex is defined as the beginning of the deflection 
in the lead where it is first visible, to the end of the deflection where it is visible 
last. QRS complex duration is considered abnormal when >110 ms. The frontal 
QRS axis is calculated from the R-wave in the different limb leads; it depends 
on age and body habitus, shifting to the left with increasing age. It is considered 
normal in adults when it is between -30º and +90º (Surawicz et al 2009).
The most recent definition of RBBB is QRS duration of at least 120 ms, in 
combination with rsr’, rsR’ rSR’ complex configuration in leads V1 or V2 and 
a broad >40 ms S wave (or broader than the R wave) in leads I and V6. More-
over, an R peak time (time from onset of QRS complex to the highest point of 
the R-wave) should be >50 ms in lead V1 (Figure 3) (Surawicz et al 2009). An 
incomplete RBBB is defined as an otherwise RBBB QRS configuration, but 
Figure 2. P-wave abnormalities. a) P-terminal force, over 1 mm deep and over 40 ms broad terminal 
negative part of P-wave in V1. b) First-degree interatrial block, broad P-wave without biphasic pattern in 
inferior leads. c) Third-degree interatrial block, broad P-wave with biphasic pattern in inferior leads.
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with a QRS duration of 110-120 ms (Surawicz et al 2009). Another definition 
of incomplete RBBB considers only the pattern R’>R in V1 or V2 (Prineas et 
al. 1982). LBBB in adults is defined as QRS duration of at least 120 ms, to-
gether with broad R waves in I, aVL, V5 and V6, absent Q waves in I, V5 and 
V6, and R peak time >60 ms in V5-V6 (Figure 4) (Surawicz et al 2009). A left 
anterior fascicular block has a QRS frontal axis between -30º and -90º (there 
is some debate on whether the limit on the right should be -30º, -40º, or -45º), 
qR pattern in lead aVL, R peak time in aVL 45 ms or more, and a QRS dura-
tion less than 120 ms (Macfarlane et al. 2011, pp 555-558). ICVD (also called 
intraventricular block) is defined as a QRS duration of at least 120 ms in the 
absence of any specific conduction block (Figure 5) (Prineas et al. 1982).
Figure 3. Right bundle branch block. Note the M-shaped rsR’ complex in V1 and the broad 
S-wave in V6.
Figure 4. Left bundle branch block. Note the broad S-wave and ST-elevation in V1 and the 
broad M-shaped R-wave in V5.
Figure 5. Intraventricular conduction delay. Note the approximately 130 ms wide QRS complex 
and lack of criteria fulfilling either right or left bundle branch block.
There exist many sets of criteria for diagnosing the presence of LVH, 
with varying degrees of sensitivity and specificity. These criteria are usually 
based on QRS-complex voltages with a possible combination of QRS-com-
REV IEW OF THE L I T ERATURE
17
plex duration and have higher specificity than sensitivity. QRS voltages are 
normally higher with increasing age, with male sex, and with a slimmer habi-
tus. Ethnicity can also influence the QRS voltages. The criteria most used are 
the Sokolow-Lyon, Cornell Voltage, Cornell Voltage duration product, and 
the Romhilt-Estes score (Table 1, Figures 6-7)) (Hancock et al. 2009).
Figure 6. Left ventricular hypertrophy according to Cornell voltage-duration product criteria. 
The sum of R-wave amplitude in aVL and S-wave amplitude in V3 is approximately 2.4 mV, and 
QRS duration is approximately 110 ms.
Figure 7. Left ventricular hypertrophy according to 
Sokolow-Lyon criteria. Sum of S-wave amplitude in V1 and 
R-wave amplitude in V6 is approximately 4.6 mV.
The presence of pathological Q-waves most of-
ten indicate prior myocardial infarction. A patho-
logical Q-wave is larger than the normal negative 
initial part of the QRS complex; in some leads, the 
QRS complex should start with either a positive 
deflection or a very small negative deflection. A 
QS complex is a QRS complex with no positive 
deflection. Criteria for diagnosis differ between 
the ECG leads, and are not specific for myocardi-
al infarction, meaning that fibrosis due to cardio-
myopathy can also cause a pathological Q-wave. 
Consensuses are few as to when Q-waves should 
be classified as pathologic; examples are the Min-
nesota code and the Myocardial Infarction Task 
Force 2007 (Prineas et al. 1982, Thygesen et al. 
2007).
The J-wave, or early repolarization pattern, is 
defined as a notched or slurred J-point elevation 
18
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in the inferior or lateral leads is a sign of electrophysiological instability (Tik-
kanen et al. 2009).
The T-wave axis is calculated based on amplitudes in the different ECG 
leads. The T-wave, representing the ventricular repolarization, is usually 
positive in leads I, II, aVL, and V2-V6. Usually the T-wave axis is close to the 
QRS-axis. The QRS-T angle is defined as the frontal axis angle between 
the QRS-axis and the T-wave axis, with an angle of >100º being considered 
broad (Aro et al. 2012b). When the amplitude is <-1 mm in the aforementioned 
leads, the T-waves are considered inverted, and are nonspecific indicators of 
repolarization abnormalities (Rautaharju et al. 2009).
The QT interval, defined as the time interval from the onset of the QRS 










Sum of the S-wave in lead V1 and the R-wave in V5 is 
>3.5 mV
Sum of the S-wave in V3 and the R-wave in aVL >2.0 mV 
for women or >2.8 mV for men
(Sum of the S-wave in V3 and the R-wave in aVL)
xQRS-duration≥0.2436 mVs for men; (Sum of the 
S-wave in V3 and the R-wave in aVL + 0.8 mV)xQRS-du-
ration ≥0.2436 mVs for women
R or S in any limb lead ≥2.0 mV, S in V1 or V2 ≥3.0 mV, or 
R in V5 or V6 ≥3.0 mV: 3 points.
ST-T vector opposite to QRS without digitalis:3 points
ST-T vector opposite to QRS with digitalis: 1 point
PTF: 3 points
QRS axis deviation more leftward than -30º: 2 points
QRS duration ≥90 ms: 1 point
Delayed intrinsicoid deflection in V5 or V6 ≥50 ms: 1 point
≥5 points is considered to be certain LVH, 4 points is 
likely, and <4 points is unlikely
Sokolow & Lyon 1949
Casale et al. 1985
Molloy et al. 1992
Romhilt & Estes 1968
Table 1. ECG criteria for left ventricular hypertrophy.
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larization time of the ventricles. The QT-time might vary significantly between 
the ECG leads, and it’s recommended that it’s measured from the lead where 
it is the longest. The QT-time is sometimes difficult to measure, and a U-wave 
can be present. The method recommended to be used in these cases is the 
tangent method, which means a tangent is drawn through the point with the 
steepest downslope of the T-wave, and the the end of the T-wave is the point 
where the tangent crosses baseline. A prolonged QT interval is a risk marker 
for potentially fatal arrhythmias (Rautaharju P et al. 2009). Usually the QT in-
terval is corrected for heart rate using formulas such as Bazett’s, Fridericia’s, 
or the Framingham formula (Bazett 1920, Fridericia 1920, Sagie et al. 1992). 
After correction, the term used is “corrected QT-interval” (QTc). Views are 
many on the limit at which QTc is prolonged: usually the limit is considered 
440-450 in men and 460-470 in women (Corrado et al. 2005, Goldenberger 
et al. 2006, Ishikawa et al. 2015).
2.1.2 The electrocardiogram and risk of atrial fibrillation and stroke
The Framingham study found a link between non-valvular AF and stroke; AF 
in the absence of rheumatic heart disease elevates stroke risk more than 
fivefold (Wolf et al. 1978). Stroke related to AF is also more severe and with 
higher case-fatality than stroke without AF (Lin et al. 1996).
LVH based on Perugia score is an independent risk factor for ischemic 
stroke (Verdecchia et al. 2001). Perugia score is also associated with asymp-
tomatic ischemic lesions, i.e. prior silent brain infarcts (Selvetella et al. 2003). 
A recent Finnish study found Cornell voltage-duration criteria, Sokolow-Lyon 
criteria, Romhilt-Estes score, and Perugia score associated with cardiovas-
cular events in women, but not in men (Porthan et al. 2015). Sokolow-Lyon, 
Cornell voltage, and Cornell voltage-duration criteria LVH criteria are asso-
ciated with increased risk of ischemic stroke, and Cornell voltage-duration 
criteria can even add additional information regardless of echocardiograph-
ic LVH (Kohsaka et al. 2005).
ECG markers associated with developing AF include a longer PR interval, 
or first-degree AV-block and advanced (third-degree) interatrial block (Ceng 
et al. 2009, Schnabel et al. 2009, O’Neal et al. 2016). Both prolonged and ab-
normally short P-waves are associated with increased AF risk (Nielsen et al. 
2015). A P-wave frontal axis outside the normal range of 0-75 degrees carries 
a slightly (17%) increased risk for developing AF (Rangel et al. 2016). Other 
20
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ECG risk factors for developing AF include left anterior fascicular block, pro-
longed QTc, and frequent premature atrial contractions (Nguyen et al. 2016). 
Even short QTc, especially type 2 short QT syndrome, is associated with a 
higher prevalence of AF. In fact, short QT syndrome has a far higher prev-
alence of AF (11-16%), than does long QT syndrome (0-2.4% depending on 
subtype) (Hasdemir 2016). LVH and diabetes also cause increased risk of 
AF (Kannel et al. 1982). Several other well-documented risk factors for AF 
include age, male sex, obesity, higher systolic blood pressure, higher pulse 
pressure, significant cardiac murmur, and myocardial infarction (Schnabel et 
al. 2009). A recent large study found that BMI has the strongest associations 
with AF risk, and the risk brought by higher BMI is higher in men (Magnus-
sen et al. 2017). The risk of progression from paroxysmal AF to persistent 
or chronic AF can be assessed by using the HATCH score, which considers 
heart failure, age, previous TIA or stroke, chronic obstructive pulmonary dis-
ease, and hypertension (de Vos et al. 2010).
2.2 Stroke in the young
2.2.1 Short history of stroke in the young
Stroke in the young is considered different from stroke in old age regarding 
risk factors and prognosis. The age limit for defining “young” stroke patients is 
various. A few larger young-stroke studies during the last decades include the 
Stroke in Young Fabry Patients (SIFAP) with age limits of 18-55 years (Rolfs et 
al. 2013), the 15 Cities Young Stroke Study with age limits of 15-49 (Yesilot Bar-
las et al. 2013), the Follow-Up of Transient ischemic attack and stroke patients 
and Unelucidated Risk factor Evaluation (FUTURE) study with age limits of 
18-50 (Rutten-Jacobs et al. 2011), the Iowa Registry of Stroke in Young Adults 
with age limits of 15-45 (Kappelle et al. 1994), the Hordaland County Study 
with age limits of 15-49 (Naess et al. 2002), and the Helsinki Young Stroke Reg-
istry (HYSR) with age limits of 15-49 (Putaala et al. 2009).
A systematic review by Marini and colleagues (2011) found incidence of 
stroke in the young to be 5.8-39.8/100 000 person-years in its studies cited, 
although it included both ischemic and hemorrhagic strokes, the proportion of 
ischemic etiology of strokes in the young ranged from 21.0% to 77.9%. An earlier 
study by Marini and colleagues (2001) found the prevalence to be 5.8/100 000 
of ischemic stroke in all persons under 45. Incidence according to the HYSR 
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was 10.8/100 000 person-years (13.3/100 000 for men, and 7.8 for women), 
finding a markedly increased incidence with rising age even within the age cat-
egory of 15-49 (Putaala et al. 2009). Kittner and colleagues, studying the effect 
of pregnancy on stroke risk, found an overall incidence of ischemic stroke of 
11.0/100 000 person-years in young women (Kittner et al. 1996). Groppo and 
colleagues (2011) found an annual rate of 7.4 (6.8 for men, 8.6 for women).
Several lines of evidence suggest that incidence of ischemic stroke in 
younger individuals is increasing. One explanation for this is the increase in 
traditional stroke risk factors among young adults (George et al. 2017). Swer-
del and colleagues (2016) found a rising incidence of stroke in those aged 
35-55 between the periods of 1995-1999 and 2010-2014, although during 
that period stroke at older ages decreased. They found that the generation 
born 1945-1954 had a lower overall prevalence of stroke than did those born 
within the prior or following 20 years. Kissela and colleagues found the mean 
age for suffering stroke (ischemic and hemorrhagic combined) declined 
during 1993-1994 to 2005, and that the proportion of stroke patients under 
age 55 significally increased from 12.9% to 18.6%. The proportion of ischemic 
strokes among young persons aged 20-44 increased during that period (Kis-
sela et al. 2012). A Norwegian study also found stroke incidence at a young 
age increasing, although the effect was seen only in women (Vangen-Lønne 
et al. 2015). Béjot and colleagues found a temporal rise in ischemic stroke in-
cidence in those aged <55 from 8.1/100 000 person-years during the period 
1985-1993 to 18.1/100 000 in 2003-2011 (Béjot et al. 2014). Rosengren and 
colleagues (2013) found an annual increase of stroke incidence in the age 
group 18-44 years of 1.3% in men and 1.6% in women. Krishnamurthi and 
colleagues (2015) estimated the global burden of ischemic stroke in 20 to 
64-year-old adults as being more than seven million patients, representing 
approximately 0.1% of that age group.
2.2.2 Risk factors for stroke at a young age
Risk factors for stroke can be classified into traditional and unconventional. 
The traditional risk factors – common to older-onset stroke – include smok-
ing, hypertension, diabetes, cardiac diseases including AF, obesity, dyslip-
idemia, and obstructive sleep apnea. Unconventional risk factors that more 
often appear in younger patients include migraine with aura, estrogen-con-
taining oral contraceptives, pregnancy, puerperium, PFO, heavy drinking, co-
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agulation pathologies, and recent infections. Few studies have assessed the 
strength of association of the traditional risk factors in the young.
In various studies, the hazard ratio for stroke borne by cigarette smoking 
ranges from 2.5 to 6.8, showing a slightly higher risk for women (Haapaniemi 
et al. 1997, You et al. 1997, Albucher et al. 2000, Lipska et al. 2007). In women, 
dose-dependence has also been investigated, showing 1-10 cigarettes per 
day to have a hazard ratio of 2.2, while ≥40 cigarettes per day had a striking 
hazard ratio of 9.1 (Bhat et al. 2008).
Hypertension is linked to ischemic stroke also in the young. The hazard 
ratio in studies ranges from 2.7 in men and non-significant in women, to 18.7 
in both sexes (Haapaniemi et al. 1997, You et al. 1997, Albucher et al. 2000). 
Having a blood pressure level of +1 standard deviation bears a hazard ratio 
of 1.9 for stroke at a young age (Lipska et al. 2007). Case-control studies 
have also found hypertension as significantly more prevalent in young stroke 
patients than in their controls (Bhat et al. 2008, Mitchell et al. 2015).
Diabetes is a well-established risk factor for stroke at a young age, with 
a hazard ratio ranging from 3.7 in men and non-significant in women, to 11.6 
overall (Haapaniemi et al. 1997, You et al. 1997, Bhat et al. 2008). However, not 
all studies have found this association to be significant (Albucher et al. 2000). 
A fasting blood sugar of +1 SD also bears a risk of stroke (Lipska et al. 2007).
Albucher (2002) found higher HDL in controls than in patients, whereas 
LDL, VLDL, and triglycerides were higher in stroke patients, this being the 
traditional view of blood cholesterol components and cardiovascular risk. 
Sabino and colleagues (2008) made a similar finding with lipoproteins: higher 
ApoB level was associated with stroke, while a higher ApoA-I level protected 
from stroke. Another study found only a lower HDL level to be associated 
with stroke, with LDL and triglycerides non-significant (Lipska et al. 2007). 
However, many studies have found no association between blood cholester-
ol and stroke (Haapaniemi et al. 1997, You et al. 1997, Bhat et al. 2008).
Obesity (BMI ≥30) is associated with stroke in the young, although adjust-
ing for hypertension and diabetes eliminated this independent association 
in Mitchell’s (2015) study, suggesting that obesity as a risk factor for young 
stroke is mediated by hypertension and diabetes. A BMI of 25.0-29.9, did not 
find significantly elevate the risk of stroke.
Chang and colleagues (2014) found obstructive sleep apnea elevating the 
risk of ischemic stroke by 19% overall, an increase most prominent in women 
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aged 20-35) having a hazard ratio of 4.9. Women aged 36-50 and men aged 
36-50 were at increased risk, with respective hazard ratios of 1.6 and 1.3.
A meta-analysis with 622 381 participants has established an association 
between migraine and ischemic stroke, finding migraine doubling the isch-
emic stroke risk (Spector et al. 2010). A study by Li and colleagues (2015) 
found the association between migraine and stroke only in individuals aged 
over 55. The use of estrogen-containing oral contraceptives and cigarette 
smoking have also modulated stroke risk that is raised by migraine, causing 
a synergistic effect (Bousser 2004). An Italian project on stroke in the young 
found migraine with aura in young stroke patients associated with fewer car-
diovascular risk factors (odds ratio 0.5), more right-to-left shunts (odds ratio 
2.4), and procoagulant states (odds ratio 2.2). They found no association of 
these with migraine without aura (Pezzini et al. 2011).
Contraceptive use increased risk of ischemic stroke by a hazard ratio of 
7.3 in the Albucher group study (2000) and 4.2 in the Haapaniemi group study 
(1997). Bhat and colleagues (2008) found no association, as also did You and 
colleagues (1997). A meta-analysis on the risk of stroke in oral-contraceptive 
users found an overall hazard ratio of 1.7 for users of combined oral contra-
ceptives containing estrogens, a risk also estrogen dose-dependent: higher 
dose increased risk. The meta-analysis did not find increased risk from using 
progestins (Roach et al. 2015).
Peripartum stroke occurs in 10.3 to 34.2 per 100 000 deliveries (Lanska 
and Kryscio 1997, James et al. 2005). Known risk factors for peripartum 
stroke are lupus, blood transfusion, and migraine (James et al. 2005), with 
most pregnancy-related brain infarctions taking place in the third trimester 
or puerperium (Jaigobin and Silver 2000). A seminal study by Kittner and 
colleagues (1996) found no excess risk of stroke during pregnancy, although 
puerperium carried a relative risk of 8.7 compared to background. 
PFO is a largely disputed risk factor for ischemic stroke. Asheikh-Ali 
(2009) did find that in stroke patients overall, the odds ratio for PFO in crypto-
genic stroke patients versus control subjects was 2.9, and in stroke patients 
younger than 55, it was 5.1. The probability of a PFO being incidental in a 
young stroke patient was 20%, although for PFO with atrial septal aneurysm, 
it was only 9%. In strictly population-based analysis, no association has been 
demonstrated between PFO and ischemic stroke (Davis et al. 2013).
Habitual heavy drinking has been a risk factor for stroke (hazard ratio 2.1), 
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although recent heavy drinking was not (You et al. 1997). However, Haapa-
niemi and colleagues (1997) did find recent heavy drinking being a risk factor 
for stroke in the young.
In one small case-control study, Syrjänen and colleagues (1989) found 
more dental infections in young stroke patients than in stroke-free control 
subjects. A few genes have also been associated with stroke in the young. 
For example, mutations at 4q25 (PITX2) and 16q22 (ZFHX3) have associat-
ed with cardioembolic stroke, and 7p21 (HDAC9) and 6p21 with large artery 
atherosclerotic stroke (Cheng et al. 2014). Kleindorfer and colleagues (2006) 
found Afro-American ethnicity as an ethnic risk factor for young stroke. High-
er amounts of air pollution particles have also been linked to increased risk 
(Yitshak Sade et al. 2015).
2.2.3 Etiology and diagnostic work-up of ischemic stroke in young patients
The etiologic classification most commonly used in clinical practice and stroke 
research is the TOAST (Trial of Org 10172 in Acute Stroke Treatment) classi-
fication (Table 2) (Adams et al. 1993). The TOAST classes have in some stud-
ies been further refined for instance by dividing cardioembolism into high- and 
low-risk sources. A newer classification system is the A-S-C-O, standing for 
atherosclerosis, small vessel disease, cardiac source, and other. The A-S-C-O 
classification differs from TOAST in the sense that A-S-C-O uses a probability 
level of each etiology in each patient, classified as potential cause, uncertain, 
and unlikely (Amarenco et al. 2009). The etiology of stroke in young patients 
has a somewhat different distribution than in older patients. For example, in the 
young, cervical artery dissection is far more common, whereas AF, small-vessel 
disease, and large-artery atherosclerosis are less common (Fromm et al. 2011).
A new construct to define stroke etiology is ESUS, excluding high-risk 
sources of cardioembolism, but otherwise seeming embolic (Hart et al. 
2014). Compared to the TOAST criteria, ESUS patients comprise in part car-
dioembolism patients (e.g. cardioembolism from low-risk or undetermined 
sources) and, according to TOAST criteria, of patients with cryptogenic IS. 
No large study has determined the ESUS fraction of stroke in young adults, 
although an estimation is approximately 40%, leaving only approximately 
10% cryptogenic patients (Ladeira et al. 2015). Clinical trials are ongoing, 
aiming to clarify whether anticoagulant therapy is more beneficial in ESUS 
patients than are antiplatelets, which could reduce the interest in extensive 
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cardiac evaluation after IS, since anticoagulant therapy would be initiated 
with or without discovering potential cardiac sources (Diener et al. 2015, 
Geisler 2016, Janssen 201).
Several studies on stroke in the young have found quite varying results on 
etiologic distribution. One reason is the varying definitions of etiologic sub-
groups. Undetermined etiology is usually the largest group, accounting for 












Clinical and brain imaging findings of >50% stenosis or occlusion of a major 
brain artery or branch cortical artery
Arterial occlusion presumably due to an embolus arising in the heart
High-risk sources:
Mechanical prosthetic valve
Mitral stenosis with atrial fibrillation
Atrial fibrillation (other than lone atrial 
fibrillation)
Left atrial/atrial appendage thrombus
Sick sinus syndrome
Recent myocardial infarction (<4 weeks) 
Left ventricular thrombus
Dilated cardiomyopathyAkinetic left ven-
tricular segmentAtrial myxomaInfective 
endocarditis 
No evidence of cortical cerebral dysfunction, normal CT/MRI examination or 
a relevant brain stem or subcortical hemispheric lesion with a diameter of less 
than 1.5 cm
Rare causes of stroke, such as nonatherosclerotic vasculopathies, 
hypercoagulable states, hematologic disorders or cervical artery dissection
No likely etiology despite an extensive evaluation, or incomplete evaluation, or 
two or more potential causes
Low- or medium-risk sources:
Mitral valve prolapse
Mitral annulus calcification
Mitral stenosis without atrial fibrillation






Nonbacterial thrombotic endocarditis 
Congestive heart failure
Hypokinetic left ventricular segment
Myocardial infarction (>4 weeks, <6 months)
Table 2. Stroke etiology according to TOAST classification (data from Adams et al. 1993).  Reprinted with permis-
sion from the American Heart Association.
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in the study by Rasura and colleagues, 11% in the study by Ji and colleagues, 
33% in the study by Nedeltchev and colleagues, 16.8% in the study by Kwon 
and colleagues, and 22.4% in the HYSR (Kwon et al. 2000, Nedeltchev et al. 
2005, Rasura et al. 2006, Putaala et al. 2009, Ji et al. 2013, Rutten-Jacobs et 
al. 2013a, Yesilot Barlas et al. 2013).
The proportion of cardioembolism (CE) varies considerably between 
studies, this variation most likely explained by differing definitions and by 
whether PFO has been classified as causal. These studies found CE frequen-
cies from 13.2% to 47% (Kwon et al. 2000, Nedeltchev et al. 2005, Rasura et 
al. 2006, Putaala et al. 2009, Ji et al. 2013, Rutten-Jacobs et al. 2013a, Yesilot 
Barlas et al. 2015). Goeggel Simonetti and colleagues (2015) found, among 
Swiss Young Stroke Study patients, CE in 32%. The most usual cause of CE 
was AF in the 15 Cities Stroke Study (accounting for 15.1% of CE cases) and 
the study by Rasura and colleagues (17%), it was PFO-related in the study by 
Ji and colleagues (76%), and dilative cardiomyopathy in the HYSR (17%) (Ra-
sura et al. 2006, Putaala et al. 2009, Ji et al. 2013, Yesilot Barlas et al. 2013).
Large-artery atherosclerosis and small-vessel occlusion were less frequent 
causes of stroke in the young, accounting for 2 to 24.3% and for 2.5 to 17.4% 
(Kwon et al. 2000, Nedeltchew et al. 2005, Rasura et al. 2006, Putaala et al. 
2009, Ji et al. 2013, Rutten-Jacobs et al. 2013a, Yesilot Barlas et al. 2013). One 
noteworthy “rare cause,” according to TOAST classification, is dissection, 
which is the most common single reason for stroke in the young, accounting 
for 10.7% of all stroke cases in the study by Kwon and colleagues, 13% in the 15 
cities stroke study, 13.5% in the study by Ji and colleagues, 15.4% in the HYSR, 
and 24% in the study by Nedeltchev and colleagues (Kwon et al. 2000, Ned-
eltchev et al. 2005, Putaala et al. 2009, Ji et al. 2013, Yesilot Barlas et al. 2013). 
The relevance of PFO has, however, been under debate, and three trials have 
recently found benefit in PFO closure after stroke, in comparison to antiplate-
let therapy alone. However, PFO closure seems to bear an increased risk of AF 
(Mas et al. 2017, Saver et al. 2017, Søndergaard et al. 2017).
The diagnostic work-up of young stroke patients, leading to determination 
of etiology, includes cardiac work-up, neurovascular imaging, and blood bio-
chemical assessment for coagulation pathologies. A recent recommendation 
on the cardiac diagnostic work-up of ischemic stroke in general appeared, al-
though it does not focus on young patients in particular (Yang et al. 2016).
The basic reason why some cardiac abnormalities cause thrombosis and 
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lead to thromboembolic stroke is in Virchow’s triad: thrombosis is due to sta-
sis of blood flow, endothelial injury, and hypercoagulability. Cardiac diseases 
lead to thrombosis mostly due to hemodynamic abnormalities (Lowe 2003). 
Since the publication of the TOAST criteria, there has appeared an update, the 
SSS-TOAST. This provides a new definition – based on annual stroke risk – of 
which cardiac sources are, without treatment, high-risk (>2%), and which are 
low-risk (2%) (Table 3) (Ay et al. 2005). The low-risk sources of cardioembol-
ic stroke are nowadays considered ESUS. In assessing these, 12-lead ECG, 
rhythm monitoring, and TTE are first-line diagnostics. Cardiac CT, cardiac MRI, 
or TEE are recommended as second-line diagnostics (Yang et al. 2016). Some 
scepticism has arisen regarding the benefits of performing TEE on ischemic 
stroke patients. However, the most recent study assessing the utility of TEE in 
stroke work-up, one involving relatively young ESUS patients (61, mean age 44 
years), found that TEE changed management for 16% (Katsanos et al. 2016).
In addition to TEE, other screening methods to determine the existence of 
PFO or other right-to-left shunts are transcranial doppler bubble test, dye-di-
lution test, and ear oximetry. One meta-analysis found, in transcranial Dop-
pler, a really good sensitivity of 97% and specificity of 93% (Mojadidi et al. 
2014). Ear oximetry and dye-dilution test are less sensitive,76% and 85%, but 
both have a specificity of 100% (Karttunen et al. 2001).
High-risk 
sources with 





<2% annual risk 
of stroke
Sources of embolism of thrombotic origin:
 – Left atrial thrombus
 – Left ventricular thrombus
 – Atrial fibrillation
 – Paroxysmal atrial fibrillation
 – Sick sinus syndrome
 – Sustained atrial flutter
 – Recent myocardial infarction (within 1 
month) 
 – Rheumatoid mitral or aortic valve disease
 – Bioprosthetic and mechanical heart valves 
 – Mitral annular calcification
 – Patent foramen ovale
 – Atrial septal aneurysm
 – Atrial septal aneurysm and patent foramen ovale
 – Left ventricular aneurysm without thrombus
 – Isolated left atrial smoke
Table 3. High- and low-risk sources of cardioembolism (data from Ay et al. 2005).  Reprinted with permission from Wiley.
 – Chronic myocardial infarction together 
with low ejection fraction less than 28%
 – Symptomatic congestive heart failure 
with ejection fraction less than 30%
 – Dilated cardiomyopathy
 – Nonbacterial thrombotic endocarditis
Sources with embolism not predominantly 
of thrombotic origin:
 – Infective endocarditis
 – Papillary fibroelastoma
 – Left atrial myxoma
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2.2.4 Recurrence and mortality after stroke in young patients
2.2.4.1 Recurrence rate
Goeggel Simonetti and colleagues (2015) found 2.7% of their patients had 
a recurrent stroke within 3 months. Leys and colleagues (2002) found an 
annual rate of 1.4% for having recurrent stroke and 0.2% of having myocar-
dial infarction within 3 years after ischemic stroke at a young age. Putaala 
and colleagues (2010) found a 5-year stroke recurrence in 9.4%, a myocar-
dial infarction in 2.4%, and any major cardiovascular endpoint in 11.5% of 
the HYSR patients.
2.2.4.2 Risk factors for recurrence
Several clinical findings or secondary diagnoses have been associated with 
recurrence of stroke; previous stroke or TIA is the strongest and most often 
documented predictor (Putaala et al. 2010, Goeggel Simonetti 2015). Both 
kidney dysfunction and large-artery atherosclerosis bear a high risk, where-
as small-vessel disease carry a lower risk of recurrence (Putaala et al. 2010, 
Redfors et al. 2012, Synhaeve et al. 2016). In addition, type 1 diabetes (T2D), 
heart failure, and higher age predicted increased risk of recurrent events 
(Putaala et al. 2010). Type 1 diabetes (T1D) is a stronger predictor for recurrent 
events than is type 2 diabetes (Putaala et al. 2011b). A higher blood pressure, 
>160/100 mmHg on admission, is associated with higher risk of stroke recur-
rence (Mustanoja et al. 2016). Genetic thrombophilia elevates risk of recurrent 
vascular events (Pezzini et al. 2009), and the accumulation of many cardiovas-
cular risk factors further elevates the risk of recurrence of stroke and other ar-
terial events (Putaala et al. 2012). One study found diabetes, dyslipidemia, and 
cigarette smoking to be associated with other arterial events after ischemic 
stroke, but not with recurrent stroke (Rutten-Jacobs et al. 2013b).
2.2.4.3 Mortality after stroke in young patients
Mortality in young stroke patients is traditionally stratified into case-fatali-
ty, involving patients dying within 30 days after stroke onset, and long-term 
mortality, involving those stroke patients dying later.
2.2.4.4 Case-fatality
Mortality is highest soon after stroke, with vascular diseases being the most 
common causes of death (Varona et al. 2004). The case-fatality rate among 
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young stroke patients ranges from 0 to 3.6% (Marini et al. 2001, Groppo et 
al. 2012, Rutten-Jacobs et al. 2013, Goeggel Simonetti et al. 2015). Factors 
associated with case-fatality are AF, drug abuse, heart failure and male sex 
(Pathak & Sloan 2009).
2.2.4.5 Long-term mortality
One study has followed young ischemic stroke patients for up to 20 years, 
finding a mortality rate of 26.8%, with an observed vs. expected mortality 
ratio of 3.9 (Rutten-Jacobs et al. 2013). Another study, with a mean observa-
tion time of 18.3 years, found a mortality of 27.2% (Waje-Andreassen et al. 
2013). Cardiovascular diseases explain most of the excess long-term mortal-
ity (Rutten-Jacobs et al. 2015). The annual mortality rate is from 1.4% to 1.6% 
(Varona et al. 2004, Aarnio et al. 2014).
The 1-year mortality after ischemic stroke is declining, according to one 
study, from 10.1% in 1987-1992 to 4.6% in 2005-2010 (Rosengren et al. 2013). 
Moreover, 4-year mortality has decreased, between 1987-1991 and 2002-
2006, by 32% for men and 45% for women (Giang et al. 2013).
2.2.4.6 Risk-factors for mortality
Recurrent stroke is a strong risk factor for long-term mortality (Aarnio et al. 
2014). Other risk factors include higher age, male sex, active malignancy, 
heart failure, heavy drinking, and higher NIHSS score (Varona et al. 2004, 
Rutten-Jacobs et al. 2013, Aarnio et al. 2014). Etiologies bearing a high risk of 
mortality are cardioembolism from a high-risk source and also large-artery 
atherosclerosis (Redfors et al. 2012, Rutten-Jacobs et al. 2013, Aarnio et al. 
2014). Diabetes is also a risk factor for death, with type 1 diabetes having 
a higher point-estimate than type 2 diabetes (Putaala et al. 2011b). More-
over, poststroke infections and kidney dysfunction bear an increased risk of 
death (Heikinheimo et al. 2013, Synhaeve et al. 2016). Silent brain infarcts 
and leukoaraiosis are also associated with increased mortality (Putaala et al. 
2011a). Elevated CRP- and homocysteine levels after stroke are also mark-
ers of increased mortality (Naess et al. 2013). Accumulation of many risk fac-
tors leads to increased mortality, compared to having only a few risk factors 
(Naess et al. 2012, Putaala et al. 2012). Stroke associated with migraine and 
a favorable outcome at discharge are associated with decreased mortality 
(Marini et al. 1999).
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2.3 The electrocardiogram in stroke
Some electrocardiographic changes from pre-stroke to post-stroke are as-
sociated with the acute phase, and after stroke these usually evolve towards 
normal. Theories have arisen as to whether the ECG pathologies are due to 
cardiac comorbidities or are neurogenic. Ischemic stroke is a cardiovascu-
lar disease, and one might think that many stroke patients have heart dis-
eases, explaining ECG abnormalities. However, individual changes in stroke 
patients’ ECG tracings, and the fact that some ECG abnormalities are relat-
ed more strongly to infarctions of certain brain areas would also support a 
neurogenic theory. The ECG in young stroke patients has been studied very 
little, so the sections below will include general stroke populations, mostly 
outside the age range of young stroke research.
2.3.1. Electrocardiographic findings in general stroke populations
In a case-control study by Bozluolcay and colleagues (2003), ECG chang-
es or abnormalities were found in 62.1% of ischemic stroke patients, while 
among controls, ECG changes occurred in only 38.9%. These changes most-
ly resembled myocardial ischemia. After infarction of the medulla oblonga-
ta, an early study found dampening of heart rate variability after the stroke; 
dampening of heart rate was most intense in the acute phase, gradually de-
creasing during the next months – which is thought to be due to autonomic 
dysfunction (Korpelainen et al. 1996). A dampening of heart rate variability is 
also associated with right-sided infarcts with insular involvement, mediated 
through autonomic dysfunction (Colivicchi et al. 2004).
QT-time prolongation is occasionally evident in an ischemic stroke’s acute 
phase, although some discrepancy exists between studies as to whether it is 
more strongly associated with left- or right-hemispheric lesions (Prosser et al. 
2007, Simula et al. 2014). QTc prolongation also frequently occurs in posteri-
or-circulation strokes, in particular those affecting the temporal lobes, with a 
stronger association with the left temporal lobe (Henninger et al. 2013). High-
er blood pressure and LVH in stroke patients are cardiovascular findings as-
sociated with prolonged QTc (Wong et al. 2005). Higher blood pressure on ad-
mission with acute stroke is also associated with QT-prolongation (Goldstein 
1979). The prevalence of prolonged QT-time in stroke patients was 45% in 
Goldstein’s, 44% in Familoni’s, and 29% in Purushothaman’s study (Goldstein 
1979, Familoni et al. 2006, Purushothaman et al. 2014). Also QT-dispersion, i.e. 
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beat-to-beat variability in the QT-interval, is higher in ischemic stroke patients 
than in healthy controls (Familoni et al. 2006, Alabd et al. 2009). QT-dispersion 
is highest in the acute phase of stroke, and is greater in infarctions with insular 
involvement (Alabd et al. 2009). Change in QT-dispersion has been linked to 
the neurologic change after thrombolysis, a decline in QT-dispersion being 
associated with a decline in NIHSS score as a sign of successful thromboly-
sis (Lazar et al. 2008). The regression slope of the QT-RR relation on 24-hour 
Holter, i.e. the amount of QT shortening with a rise in heart rate, is greater 
in cardioembolic stroke than in atherosclerotic stroke (Fujiki & Sakabe 2016). 
The reason for QT prolongation in stroke is thought to be increased sympa-
thetic activity, since QT prolongation in stroke is associated with increased 
blood norepinephrine concentration (Sander et al. 2001).
ST-level depressions and T-wave inversions are frequent findings in isch-
emic stroke, and according to Goldstein’s study (1979), 39% of his stroke 
population had these changes, although only 21% had these changes prior 
to stroke. In the Purushothaman group’s study (2014), ST-segment depres-
sion occurred in 33% and T-wave inversions in 34%. In the Familoni group’s 
study (2006), the prevalence of ischemic-like changes was 55%. ST-level 
depressions have emerged in a case report of an ischemic stroke patient 
who later had a myocardial perfusion map which was normal, suggesting 
that ST-changes were not caused by myocardial ischemia, but rather were 
a reflection of the ischemic stroke per se (Chua et al. 1998). Even T-wave in-
versions are thought to be caused by increased sympathetic tone (Mandrioli 
et al. 2004). T-wave inversions have also occurred even before the onset of 
neurologic symptoms (Lindberg & Jauch 2006).
U-waves, also related to ischemic stroke, seem to be independent of se-
rum potassium levels: 28% of patients presented with U-waves, and 13% of 
these patients had new U-waves not found in prior ECG tracings (Goldstein 
1979, Purushothaman et al. 2014). Early repolarization is found in 7.0% of 
ischemic stroke patients (Bobinger et al. 2015).
The most frequent cardiac arrhythmia in ischemic stroke patients is AF, 
with a prevalence of 14% (Goldstein 1979) to 18% (Familoni et al. 2006). Sinus 
arrhythmia and ventricular tachycardias have been present in approximately 
5% of patients (Goldstein 1979). Extrasystoles, supraventricular tachycar-
dias and non-sustained ventricular tachycardias are more frequent in pa-
tients with right-sided infarction with insular involvement, than in patients 
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with left-sided infarction or right-sided infarction without insular involvement 
(Colivicchi et al. 2004). Ventricular arrhythmias are thought to occur in acute 
stroke due to sympathetic hyperreactivity and decreased parasympathetic 
activity (Koppikar et al. 2013) One study found tachycardia >120/min in 15% 
of patients, and bradycardia <45/min in 5% (Ritter et al. 2011).
Although AF is a strong risk factor for stroke, a theory has also arisen 
of neurogenic AF, i.e. of AF being a consequence of stroke rather than a 
cause. The main clinical research evidence for neurogenic AF remains that 
of Gonzáles Toledo’s study (2013), finding that stroke patients with AF found 
only after the stroke tend to have much lighter cardiovascular risk factors and 
comorbidities than do those whose AF was found prior to stroke. Moreover, 
insular infarctions, which are not typical for cardioembolic stroke, were more 
common in patients with newly diagnosed AF than in patients with known 
AF or sinus rhythm. These results seem credible, although they involve many 
confounding factors: patients with AF found after stroke had more cardio-
vascular risk factors and comorbidities than patients in sinus rhythm. This 
can also mean they are in the beginning of the natural history of AF, and it has 
not been diagnosed earlier.
2.3.2. The role of the electrocardiogram in stroke prognosis
In Goldstein’s early study, the only marker of higher mortality was malignant 
arrhythmias, i.e. ventricular tachycardia, ventricular fibrillation, and asystole 
(Goldstein 1979). McDermott and colleagues (1995) found ventricular tachy-
cardia associated with a higher rate of cardiac death after stroke and found 
no prognostic significance in ST-segment depression. However, other stud-
ies have found ischemic changes as being a marker of diminished prognosis 
(Bozluolcay e. al. 2003, Wira et al. 2011, Purushothaman et al. 2014). AF is 
a marker of increases in both short-term and long-term mortality, although 
Kimura and colleagues found it increasing mortality only in patients with mild 
stroke (Kaarisalo et al. 1997, Kimura et al. 2005, Wira et al. 2011, Hjalmars-
son et al. 2012). Prolonged QTc, U-waves and pathological Q-waves are also 
ECG markers of higher mortality after IS, as is abnormal heart rate variability 
on Holter (Dogan et al. 2004, Mäkikallio et al. 2004, Tanaka et al. 2004, Stead 
et al. 2009, Hjalmarsson et al. 2012).
One large study found AF as being a marker not only for higher short- and 
long-term mortality in stroke patients, but also as a marker of higher risk of 
REV IEW OF THE L I T ERATURE
33
stroke recurrence (Marini et al. 2005). Frequent premature atrial contrac-
tions are also a risk factor for recurrence in cryptogenic stroke patients, and 
the same study found larger atria in patients with more premature atrial con-
tractions, probably reflecting atrial disease (Pinho et al. 2015).
2.3.3. Searching for atrial fibrillation
Although diagnosis of AF always needs ECG verification, perhaps the sim-
plest and cheapest way of screening AF is by peripheral pulse palpation. A re-
cent study found a good specificity of palpation by health care professionals 
(94.0%), patients’ relatives (92.9%), and by the patients themselves (96.2%). 
The sensitivity was not as good: 96.5%, 76.5%, and 54.1% (Kallmünzer et al. 
2014). AF can also frequently be silent, i.e. without symptoms, which can also 
lead to AF going undetected during pulse palpation or any other intermittent 
method. Device screening of AF therefore belongs to the routine diagnostic 
work-up, mostly with Holter and other long-term rhythm-monitoring meth-
ods. Device detection can be divided into different levels: admission ECG, 
serial ECG, continuous inpatient monitoring, outpatient Holter, external loop 
recording, and implantable loop recording. No consensus exists yet as to 
how many levels of AF detection should be used after IS, but a recent me-
ta-analysis investigated the benefits of different monitoring methods. Over-
all AF detection rate was 23.7%, combining all levels of device detection; 7.7% 
were found by only admission ECG, 5.1% by serial ECG and inpatient moni-
toring, 10.7% by short-term ambulatory Holter, and 16.9% long-term external 
recording and implantable loop recording (Sposato et al. 2015). The search 
for AF after stroke has reached epic proportions during recent years. The 
main reason is the possibility to enhance prognosis by initiating anticoagu-
lant therapy for a patient with AF and stroke (Freeman & Aguilar 2011).
A study by Douen and colleagues suggests that serial ECG assessment in 
stroke patients during the first three days after admission enhances AF detec-
tion 2.6-fold, compared to admission ECG only, and that its detection rate was 
similar to that of 24-hour Holter alone, although a combination of serial ECG 
and Holter gave the best detection rates (Douen et al. 2008). An early study on 
the idea of seeking for AF in ischemic stroke or TIA patients was published by 
Abdon and colleagues (1982), finding on 24-hour Holter some type of supra-
ventricular arrhythmia in almost half the 103-patient population, mean age 68. 
Another early study found the explanation for stroke or TIA on 48-hour moni-
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toring in 6.5% of patients, and in the same population (184 patients, mean age 
63.5) 2D-echocardiography found some etiology in 17.3% (Rem et al. 1985).
In an Asian study, 15% of patients admitted for stroke were detected with 
persistent or permanent AF, and an additional 7% with paroxysmal AF. They 
did find Holter beneficial in detecting paroxysmal AF, although it was most 
frequent in patients over age 70 (Sutamnartpong et al. 2014). One meta-anal-
ysis found that outpatient monitoring by 24-hour Holter may raise AF detec-
tion rate, and that female sex and higher age led to inceased yield (Kishore 
et al. 2014). A study with mean age 69 found AF or atrial flutter yield by 24-
hour external loop recorder being 5%, although the yield in high-risk patients 
was 17% (cryptogenic stroke and cortical or subcortical symptoms) (Plas et 
al. 2015). A large study (425 patients, mean age 68) found paroxysmal AF in 
stroke or TIA patients in only 2.1%, and they also concluded that this finding 
rarely affected treatment (Schaer et al. 2004).
During recent years, AF detection after stroke has been examined with 
longer rhythm-monitoring. A 2012 German study with a median age of 71, 
using continuous monitoring for at least 72 hours, detected AF in 6.8% of 
stroke or TIA patients who did not have it on admission, whereas 24-hour 
Holter detected only 1.0% (Gumbinger et al. 2012). In the Find-AF study, the 
prevalence of AF was strongly associated with stroke patient’s age, the yield 
of 7-day Holter recording being 5% in patients under age 65 and up to 39% in 
patients over 89 (Wachter et al. 2013). Another study found that 24 hours of 
monitoring identified only 69% of the AF cases found by 96-hour monitoring 
in patients with cryptogenic stroke or TIA (Manina et al. 2014). Although many 
AF-detection studies have included both stroke and TIA patients, a Danish 
study enrolling only TIA patients (mean age 68), found, on 7-day Holter moni-
toring AF in only 2 of their 169 patients (1.2%) (Pedersen et al. 2016).
Portable intermittent devices have also been tested for the detection of 
post-stroke AF. An early study found a higher yield of AF by using an auto-
mated event recorder for 1-4 days, although the recorder failed to find all the 
cases of paroxysmal AF found by Holter (Barthélémy et al. 2003). A portable 
intermittent (10-second rhythm samples a few times daily) long-term ECG 
follow-up device found AF on 30-day follow-up in 11.8% of patients in a pop-
ulation in which 24-hour Holter found it in only 6.8%, although Holter did de-
tect it in 2 patients (0.8% of the population) missed by the intermittent device 
(Doliwa Sobocinski et al. 2012).
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An early study of one-month rhythm monitoring involving 20 cryptogenic 
stroke patients and an external device worn continuously except for bathing, 
found AF present in 4 (20%) patients (Elijovich et al. 2009). Another small 
study on considerably younger cryptogenic stroke patients (24 patients, 
mean age 49 years) found no significant AF in any of the included patients, 
with a mean follow-up of 14.5 months (Dion et al. 2010). The EMBRACE trial, 
the largest long-term extracorporeal rhythm monitoring trial by far, used the 
device for 30 days and detected AF of at least 30 seconds duration in 16.1% 
whereas, of their patients with standard treatment, i.e. 24-hour Holter, only 
3.2% were diagnosed with AF (Gladstone et al. 2014).
The era of implantable devices has already produced several studies. 
One, following 22 cryptogenic stroke patients (mean age 61.6) for one year 
by use of an implantable rhythm recorder, detected AF in 6 (27%) (Etgen et al. 
2013).  The SURPRISE study had a larger population of 85 patients; with an 
implantable loop recorder during a mean of 569 days, they found previously 
unknown AF in 16.1%. The mean time of monitoring until finding AF was 109 
days (Christensen et al. 2014). CRYSTAL AF, the largest implantable loop re-
corder study by far, found AF within 6 months in 8.9%, and within 3 years in 
30.0%, their yield with standard diagnostics being 1.4% and 3.0%, respective-
ly (Sanna et al. 2014).
Some questioning of the idea of searching for brief periods of AF occur-
ring after stroke has also emerged. The TRENDS study involved patients 
with ischemic stroke and a previously implanted pacemaker or ICD device, 
all of whom had been detected with AF of at least 5 minutes. The study found 
that most of the patients had AF of at least 6 hours, suggesting, in the AF-
stroke association a dose-dependence (Ziegler et al. 2010).  Another pace-
maker study on patients with known AF found AF burden (i.e. how large 
fraction of time the patient is in AF) being a strong marker of stroke risk, in 
addition to CHADS2 score, making a combination of these two risk markers 
a better risk predictor than CHADS2 score alone (Botto et al. 2009). Arsava 
and colleagues (2015) found non-sustained (<30 s) AF episodes as frequent-
ly in other stroke etiologic groups as in cryptogenic stroke patients, calling 
into question the causality of these short AF episodes in those cryptogenic 
cases. Another study also found paroxysmal AF in patients with cryptogen-
ic stroke and in patients with stroke of determined cause similarly common, 
although the younger patients (<65), showed more paroxysmal AF in the oth-
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erwise cryptogenic group, suggesting a stronger causality in those patients 
(Rabinstein et al. 2013). Tagawa and colleagues (2007) investigated AF yield 
in a stroke population of mixed etiologies, finding AF on 24-hour Holter in 
67.6% of patients with cardioembolic stroke, in 15.2% with lacunar stroke, 
and in 9.2% with atherothrombotic stroke, showing AF to be detectable in 
many patients with other potential sources. 
In addition to investigating the yield of different monitoring methods, some 
studies have also tried to find the optimum length of such monitoring, with 
various results. One study found that most cases of AF emerged in the begin-
ning of monitoring, and prolonging the monitoring for more than five days did 
not significantly raise the AF yield (Suissa et al. 2013b). Another study, using 
3-week telemetry in a stroke population with mean age of 68.5, found signifi-
cant increases in the detection rate during each additional week: cumulative 
increase in detection 3.9% after the first 48 hours, 9.2% after the first week, 
15.1% after 2 weeks, and 19.5% after three weeks (Miller et al. 2012).
Some studies have also investigated the cost-effectiveness of searching 
for AF and in decision-making regarding initiating anticoagulant therapy 
and directing it to those patients who truly need it. A recent Swedish study 
compared the cost-effectiveness of 24-hour Holter-ECG and an intermittent 
monitoring device for 30 days. The results were in favor of the intermittent 
monitoring device, with the 24-hour Holter lacking to be cost-effective. That 
study found no AF in patients <65 years of age, and the cost-effectiveness in-
creased with increasing age (Levin et al. 2015). Another study found it benefi-
cial to use automation in AF detection on telemetry, a comparison using only 
human detection versus tachy- and bradycardia detection (Kallmünzer et al. 
2012). A meta-analysis of outpatient monitoring of two days to three weeks 
after ischemic stroke found that to be cost-effective, the price of a quality-ad-
justed life year being approximately 13000 US dollars; they recommend at 
least one week of monitoring (Kamel et al. 2010). Both the EMBRACE and 
CRYSTAL AF groups further analyzed the cost-effectiveness of their diag-
nostics: EMBRACE found the price for a quality-adjusted life year to be 2 
000 US dollars, whereas the cost in the CRYSTAL AF trial was over 13 000 
pounds per quality-adjusted life year (Diamantopoulos et al. 2016, Yong et 
al. 2016). This discrepancy in costs reflects not only the device cost, but also 
the diagnostic yield of the screened population, and the lower cost-effective-
ness of CRYSTAL AF is partially due to their population being younger.
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2.3.4. Prediction of atrial fibrillation risk after stroke
In addition to detecting AF with certainty, i.e. on ECG, some focus has also 
been placed on finding secondary signs and building predictive models in 
which stroke patients are at increased risk of AF. Directing the rhythm di-
agnostic screening towards high-risk patients could further increase the 
cost-effectiveness of AF screening after stroke. However, one study found 
no significant results from stratifying stroke patients according to known 
cardiac disease and found a striking cost-effectiveness of 1 300 Australian 
dollars per detected AF case by using Holter monitoring (Atmuri et al. 2012). 
Findings carrying an increased probability of detecting AF after stroke ap-
pear in Table 4.
In addition to single parameters increasing AF yield, a few predictive mod-
els with multiple parameters have also been constructed. The STAF score 
includes age (>62 years), NIHSS score  ≥8, left atrial dilation on echocardi-
ography, absence of symptomatic intra- or extracranial ≥50% stenosis, and 
absence of lacunar syndrome. The STAF score ranges from 0 to 8, a score of 
≥5 having a sensitivity of 89% and a specificity of 88%. Adjusting the thresh-
old higher increases specificity at the expense of specificity, and vice versa 
(Suissa et al. 2009). A Japanese risk score for AF was developed by Fujii and 
colleagues (2013), based on NIHSS score, left atrial size, mitral valvular dis-
ease, and BNP level, finding 0/5 points as to have 100% specificity and 5/5 
points to have 100% sensitivity. Yoshioka and colleagues (2015) developed 
a more advanced scoring system for stroke patients (the iPAB score), based 
on those clinical parameters associated with AF after stroke. A history of ar-
rhythmia gave 3 points, left atrial dilation on ECG (equal to PTF) 1 point, and 
blood BNP-level 1-3 points. Screening only patients with 2 points or more 
gave a sensitivity even of 93% for detecting AF.
2.3.5. The electrocardiogram in young stroke patients
Thus far, ECG in young stroke patients has not been extensively studied. 
Only a few papers involving this patient population deserve attention. An 
early study on acute-phase (less than 24 hours after symptom onset) ECG 
in young stroke patients comes from Sweden (Hindfelt & Nilsson 1976). This 
study included only 44 patients, of whom 15 had abnormal ECG and con-
cluded that ECG abnormalities in young patients with ischemic stroke and 
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without other cardiovascular abnormalities are usually benign, limited to 
ST-T changes, sinus tachycardia, and sinus arrhythmia. They also concluded 
that ECG abnormalities were much more common in their older stroke pa-
tients, reflecting cardiovascular burden increasing with age (Hindfelt & Nils-
son 1976). Interestingly, Kallmünzer and colleagues (2011) described a case 
of temporary J-wave in a young stroke patient.
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Holter figures for AF in young stroke patients range from 1% in the study 
of Ji and colleagues (2013) in a population of mixed stroke patients, to 10.2% 
in the study of Šaňák and colleagues (2015), including young cryptogenic 
stroke patients and using up to 3 weeks of monitoring, with the Prefasi group 
(2013) being intermediate with 8.9%. NIHSS ≥8 was associated with AF in 
young IS patients in one of these studies (Prefasi et al. 2013).
2.4. Research and theories on atrial abnormalities and their 
relation to stroke
The association between AF and ischemic stroke has been well estab-
lished during the last few decades, although a novel theory on the relation 
has emerged. Atrial cardiopathy, or fibrous atrial cardiopathy, meaning re-
modeling of the atria due to disease, is a well-established phenomenon as 
a consequence of AF, however, its fibrous changes are possibly not only a 
consequence of AF, but also a cause, indicating a more complex relation-
ship. Many inflammatory biomarkers have been associated with the fibrotic 
changes of atrial remodeling in AF (Hirsh et al. 2015, Bayés de Luna et al. 
2016). ‘AF begets AF’ as a saying means that the more AF rhythm is present, 
the more it will remodel the atria and come to dominate. One therapeutic 
benefit of losartan has been its slowing of the progression of AF remodel-
ing (Wachtell et al. 2005). Maintenance of sinus rhythm with cardioversion 
has led to reversal of atrial remodeling, at least on the level of atrial electric 
activity (Lehto et al. 2009).
The pathogenesis of thromboembolism in AF is complex and involves en-
dothelial dysfunction, abnormal flow patterns within the left atrial append-
age due to lack of contraction and hence abnormal blood flow, procoagulant 
properties of the blood, inflammation, structural pathology and myocardi-
al and neurohumoral factors (Hirsh et al. 2015). Risk of thrombosis is also 
associated with left atrial appendage morphology, as well as with poor left 
atrial function (Pollick & Taylor 1991, Di Biase et al. 2012). The CHA2DS2-
VASc-score used for thrombosis risk stratification in AF provides a clue to 
the thrombosis risk factors aside from AF rhythm. This has also given birth to 
a suggestion for using anticoagulant therapy on those with markers of atri-
al cardiopathy and a high-risk CHA2DS2-VASc-score without AF (Bayés de 
Luna et al. 2016).
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Markers of atrial pathology include PTF and interatrial blocks in ECG, atri-
al extrasystoles and supraventricular tachycardias, left atrial enlargement in 
echocardiography, and elevated pro-BNP (Chhabra et al. 2014, Yaghi et al. 
2015, Kamel et al. 2016).
2.4.1 P-terminal force
The Northern Manhattan Study (mean age 70) found PTF associated with 
ischemic stroke (hazard ratio 1.20) to be the association most marked in the 
cardioembolic and cryptogenic subgroups, and an association independent 
of AF history (Kamel et al. 2015a). The Atherosclerosis Risk in Communities 
Study (mean age 54) found PTF increasing ischemic stroke risk by a hazard 
ratio of 1.33, an association present only in nonlacunar stroke and not occur-
ring in the subgroup of <54-year-olds (Kamel et al. 2015b). Another African 
study found PTF very strongly associated with ischemic stroke. These pa-
tients had not specifically suffered cardioembolic stroke, although they were 
admitted to a cardiology department, suggesting at least a suspicion existed 
(Soliman et al. 2010).
2.4.2 Interatrial blocks
Ariyarajah and colleagues (2007) found IAB, defined as P-wave duration 
≥110 ms, to be more common in hospital patients with a history of stroke or 
TIA. Patients with IAB also had a higher prevalence of left atrial enlargement, 
left atrial thrombi, and left atrial smoke. Lorbar and colleagues (2005) found 
as many as 80% of their embolic stroke patients in sinus rhythm having IAB 
(P≥110 ms). P-wave duration ≥120 ms is also associated with atrial high-rate 
episodes, which in turn are associated with AF and stroke (Tekkesin et al. 
2016). The Atherosclerosis Risk in Communities Study found an association 
between advanced interatrial block, i.e. third-degree interatrial block, and 
ischemic stroke. That study followed 14 716 patients for a median of 22 years, 
finding 8.05 cases of ischemic stroke per 1 000 person-years among those 
with third-degree IAB, but only 3.14 cases in those without it. This finding was 
independent of known AF, although after multivariate adjustment, the finding 
remained only in patients ≥54 (O’Neal et al. 2016).  An abnormal P-wave (PTF 
or duration over 120 ms), is associated with increased stroke risk regardless 
of echocardiographic left atrial size, showing that atrial pathologies are not 
completely explained by any single diagnostic method (Kohsaka et al. 2005).
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2.4.3 Other ECG markers
Larsen and colleagues (2015) found excessive supraventricular ectopy on 
Holter (≥ 30 beats per hour, or runs of ≥20 beats) to be associated with isch-
emic stroke, and in the presence of a CHA2DS2-VASc ≥2, having a stroke 
risk of 2.4%, comparable to that of AF. Todo and colleagues (2009) found 
premature atrial contractions as frequent in those with cryptogenic stroke as 
in those with cardioembolic stroke.
2.4.4 Other markers of atrial cardiopathy
One imaging method for measuring the degree of atrial fibrosis is late 
gadolinium enhancement on cardiac MRI. Atrial fibrosis can be classed 
by Utah stage, Utah I meaning 0-5% late gadolinium enhancement, Utah 
II 5-20%, Utah III 20-35%, and Utah IV >35%. Degree of fibrosis is usually 
greater and more irreversible in patients with lone AF than in patients with 
mitral-valvular AF, although 10% of lone AF patients show very little fibro-
sis. Another way to measure atrial fibrosis is by invasive electroanatomic 
mapping, where a fibrotic atrial substrate shows lower voltage than does 
healthy atrial substrate (Kottkamp 2013). Degree of atrial fibrosis and the 
presence of left atrial appendage thrombi as well as degree of fibrosis and 
stroke risk in AF patients have been documented. These results suggest 
that fibrosis degree could be used as an independent risk marker of stroke 
in patients with AF (Deccarett et al. 2011, Akoum et al. 2013). Yaghi and 
colleagues found markers of atrial cardiopathy (elevated pro-BNP, PTF, en-
larged left atrium on echocardiography) in 63% of their cryptogenic stroke 
patients, and the findings were increasingly common with increasing age 
(Yaghi et al. 2015).
Lai and colleagues found left atrial dimension index associated with 
stroke only in women (hazard ratio 2.44 for highest tertile compared to 
lowest), but not in men, in a Chinese ethnic population (Lai et al. 2011). 
Another study found a modestly increased left atrial size (29-33 ml/m2) 
associated with atherothrombotic stroke, probably due to hypertension 
as an underlying factor for both findings, although markedly increased 
left atrial size (>33 ml/m2) was associated with cardioembolism (Shaikh 
et al. 2013). A small study found that atrial tachycardias were not more 
common in cryptogenic stroke patients than in control subjects (Fuchs & 
Torjman 2015).
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3 AIMS OF THE STUDY
The aim of this study was to investigate ECG findings in young IS patients 
and their significance:
1. To characterize ECG changes in a large database of consecutive 
young patients with ischemic stroke.
2. To assess ECG markers associated with cardiac events and stroke 
in the follow-up of young ischaemic stroke patients
3. To clarify ECG markers bearing higher mortality risk in young isch-
aemic stroke patients
4. To compare ECG findings of young IS patients to age- and sex-
matched healthy controls with particular interest of ECG findings 
associated with cardioembolism from high-risk sources and ESUS
Our hypotheses were that there would be more ECG pathologies in the 
cardioembolism group than in the other etiologic groups (I), that ECG mark-
ers associated with cardiac events in the general population would bear 
increased risk also in young IS patients (II), that ECG markers bearing in-
creased IS risk in the general population would bear increased risk of stroke 
recurrence in young IS patients (II), that ECG markers bearing higher mor-
tality in the general population would be markers of higher mortality also 
in young IS patients (III), and that ECG markers of LVH and atrial pathology 





Studies I-III were each of a retrospective nature, and included 690 of the 
1008 HYSR patients (patient flow; see Figure 8). All patients were 15 to 49 
years old, and were treated for IS during the years 1994 to 2007.
The patients were examined by a standard protocol described in more 
detail earlier (Putaala et al. 2009). ECG was obtained on admission, and in 
most cases also at least once more after the visit to the emergency room 
(ER). We included only ECG recordings obtained at least one day after ad-
mission, in order to minimize acute-phase ECG changes. Furthermore, we 
excluded ECG recordings not obtained within two weeks of stroke-symp-
tom onset, and some patients were also excluded due to their ECG being 
of insufficient technical quality. The included patients had higher NIHSS 
scores and a higher prevalence of cardiovascular diseases (P=0.014 and 
0.036, respectively), but did not differ otherwise, regarding demographic 
and clinical aspects.
In Study IV, we included 567 patients from the HYSR, with sinus rhythm 
on their in-hospital ECG and ECG quality sufficiently good for manual anal-
ysis. We selected control subjects from among the 7217 participants of the 
Mini-Finland Health Survey enrolled during the period from 1978 to 1980 
and representing the Finnish population 30 years and over (Aromaa et al. 
1985). For Study IV, we selected 1067 municipality-, age-, and sex- matched 
controls among those free of IS. One or two control subjects were selected 
for each HYSR patient. Sex and age were selected by individual matching, 
age by the nearest available matching. Age was considered matched when it 
was ±5 years the age of the patient; therefore, patients younger than 25 were 
ruled out due to lack of any control subjects.
4.2 Methods for clinical evaluation and comorbidities
Stroke characteristics considered in Studies I-III were stroke severity, stroke 
etiology, lesion size and lesion multiplicity (one or more lesions). Stroke 
severity was assessed with the NIHSS (Brott et al. 1989). Lesion size was 
based on templates with slight modifications, a small lesion being <1.5 cm, 
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medium being involvement of a cortical superficial branch of the anterior, 
middle, or posterior cerebral artery, and a large lesion meaning involvement 
of the complete area of these main arteries (Paciaroni et al. 2008). Etiology 
was assessed by the TOAST classification, with slight modifications, involv-
ing the formation of a separate group of dissections and separate groups for 
cardioembolism from high- and low-risk sources (HRCE and LRCE) (Adams 
et al. 1993). LRCE involved PFO. HRCE involved the etiologies with an an-
nual stroke risk exceeding 2%: AF or atrial flutter, dilated cardiomyopathy, 
recent myocardial infarction, congenital heart disease, infective endocardi-
tis, mechanical aortic valve, congestive heart failure, thrombotic endocardi-
tis, and atrial myxoma (Ay et al. 2005). In addition to dissection, HRCE and 
LRCE, and rare causes excluding dissections, we used the LAA, SVD, and 
undetermined (cryptogenic) groups without modifications.
Study IV used the classification LAA, HRCE, SVD, other, and non-ESUS 
cryptogenic. We also included an ESUS group, according to recently pro-
posed criteria (Hart et al. 2014). Our ESUS criteria were as follows: non-lacu-
nar stroke detected by CT or MRI, no atherosclerosis >50% in arteries sup-
plying the ischemic area, no detected HRCE or other explaining etiology. At 
least transthoracic echocardiography was performed, and AF was screened 
for with either 24- or 48-hour Holter, repeated ECGs, or telemetry, for all pa-
tients who eventually were in the ESUS group. The arterial imaging of ESUS 
patients was computed tomography angiography, magnetic resonance an-
giography, or ultrasound imaging. Patients with an incomplete diagnostic 
work-up were classified into the non-ESUS cryptogenic group, as were pa-
tients not fulfilling the other ESUS criteria.
In Study I, we considered the following comorbidities: obesity, hyperten-
sion, cigarette smoking, dyslipidemia, congestive heart failure, preexisting 
AF, type 1 diabetes (T1D), type 2 diabetes (T2D), and cardiovascular disease 
(any of pre-existing coronary heart disease, congestive heart failure, prior 
myocardial infarction, or peripheral artery disease). We also considered age 
and sex as confounders.
In Study II, we considered as confounders age, sex, obesity, hypertension, 
smoking, dyslipidemia, congestive heart failure, known AF, coronary artery 
disease, peripheral arterial disease, and T1D and T2D.
In Study III, we considered the demographic factors age and sex, and the 
comorbidities obesity, hypertension, smoking, dyslipidemia, known AF, car-
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1008 patients in the Helsinki 
Young Stroke Study
4 with wrong primary diagnosis
48 with unknown exact stroke date
25 treated as outpatients only
162 with no ECG archived or obtained 
after ER
14 with the only ECG after ER taken 
within the same day as stroke onset
65 with no ECG taken between the day 






690 patients in ECG analysis
Figure 8. Patient flow in selection for Studies I-III. Permission to reproduce granted under Elsevier’s general terms.
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diovascular disease, T1D, T2D, malignancy, and heavy drinking.
In Study IV, we considered systolic and diastolic blood pressure, HDL cho-
lesterol, obesity, diabetes, coronary artery disease, and cigarette smoking. 
Small differences appeared in the comorbidity definitions in the patient- and 
control populations, since their medical history-taking differed slightly differ-
ent; more definitions of comorbidities are presented in Appendix Tables 1-2.
4.3 ECG analysis
The author of this thesis, blinded to clinical data at that time, analyzed the 
ECG recordings: in uncertain cases he consulted with two senior cardiol-
ogists (Mika Lehto and Aapo Aro) for a consensus judgment (Studies I-III). 
Manual measurement of P-waves and for Study IV was performed by Jani 
Pirinen and Antti Eranti.
In Studies I-III we measured the following ECG parameters: heart rate, 
P-wave duration, P-wave axis, PR-interval, QRS-complex duration, QRS 
frontal axis, T-wave frontal axis, and QT-interval. Automatic measurements 
performed by the ECG device were accepted, when available (Kligfield et al. 
2007). The angle between the QRS frontal axis and the T-wave frontal axis 
(QRS-T angle) was calculated by simple subtraction. To investigate ECG cri-
teria of LVH, we used the criteria by Sokolow-Lyon, Cornell Voltage Criteria, 
and Cornell Voltage duration product (Sokolow & Lyon 1949, Casale et al. 
1987, Molloy et al. 1992). PTF served as a binary parameter and was consid-
ered positive when the terminal negative part of the P-wave in lead V1 had a 
duration of at least 40 ms and was at least 0.1 mV in negative amplitude (So-
liman et al. 2010). We used the threshold of 120 ms to consider a P-wave pro-
longed in Studies I-III. We measured Q-waves in leads I, II, III, aVF, aVL, and 
V2-V6. Our criteria for a Q-wave to be considered pathological were ≥1 mm 
in depth and >30 ms in width in two adjacent frontal leads (I, aVL or II, aVF, III), 
or ≥ 1 mm and 20 ms in lead V2-V6. T-wave inversions were measured in V2-
V6, aVL, I, II, and aVF. The threshold for considering a T-wave inverted was 
a negative amplitude of at least 1 mm. A J-wave (early repolarization) was 
considered positive with a notch or slur >1 mm in at least 2 adjacent inferior 
leads (II, aVF, and III), or lateral leads (I, aVL, V4-V6). We used the American 
Heart Association’s (AHA) standard criteria to investigate the presence of 
LBBB, RBBB, and partial RBBB (Surawicz et al. 2009). We used the defini-
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tion IVCD when QRS-duration exceeded 120 ms in the absence of any spe-
cific block. AV-blocks and extrasystoles were also considered, according to 
standard criteria. We used the formula QTc=QT/(√RR-interval) to calculate 
the corrected QT-time (Bazett 1920). QTc was considered prolonged when 
exceeding 450 ms in men and 470 ms in women. A major ECG abnormality 
was defined as the presence of a pathological Q-wave, T-inversions, LBBB, 
RBBB, IVCD, prolonged QTc, rhythm other than sinus, PTF, LVH or a QRS-T 
angle exceeding 110 degrees.
In Study IV, P-wave duration we measured manually from the ECGs with a 
paper speed of 50 mm/s and 0.1 mV/mm amplitude. Any biphasic P-waves in 
inferior leads were also assessed. First-degree interatrial block (IAB) was de-
fined as P-wave duration ≥110 ms. Third-degree IAB was defined as P-wave 
duration of ≥110 ms and the presence of biphasic P-waves in at least two 
inferior limb leads (Chhabra et al. 2014). P-waves were considered abnormal 
when either IAB of first or third degree, or PTF was present.
4.4 Follow-up and definitions of endpoints after IS
In Study II, we used the Care Register for Health Care to obtain follow-up 
data until the end of 2011. It contains data on almost all hospital stays in Fin-
land, and its quality has proven high (Rapola et al. 1997).We scanned for the 
ICD-9 codes 391-398, 402, 404, 410-417, 420-437, 440-444, 446-447, 449, 
451-453, 459, and 798. ICD-10 codes screened for were I01, I02, I05-I09, 
I11, I13, I20-I28, I30-I52 I60-I68, I70-I79, and G45.9. When possible, we also 
certified these diseases and rightfulness of diagnoses from patient files. 
We included only those endpoints occurring at least 30 days after the index 
stroke. The specific diagnosis codes for each follow-up event are in Table 6. 
We obtained data on deaths and causes of death until the end of 2011 for 
Studies II and III from Statistics Finland. The reliability of this register is de-
scribed elsewhere (Official statistics of Finland 2013).
The primary endpoint in Study II was a composite of any cardiovascular 
events: stroke,  TIA, acute myocardial infarction, unstable angina pectoris, 
critical limb ischemia, aortic dissection, aortic aneurysm, revascularization 
procedure of large arteries, hospitalization due to arrhythmia, cardiomy-
opathy or congestive heart failure, or death due to cardiovascular disease. 
The latter we defined as the underlying, immediate or intermediate cause 
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of death being from the category of cardiovascular diseases (390 to 459 in 
ICD-9 or category I in ICD-10). Death due to index stroke was considered a 
cardiovascular event if more than 30 days had elapsed since the stroke. In 
cases with multiple consecutive events, only the first event was included in 
the composite event. In cases of acute myocardial infarction, unstable an-
gina pectoris, coronary angioplasty, hospitalization due to arrhythmia, car-
diomyopathy, or congestive heart failure, or death due to cardiac causes, a 
patient was considered to have suffered a cardiac event. IS or hemorrhagic 
stroke, but not TIA, were considered as recurrent strokes.
In Study III, the primary endpoint was death from any cause. We also con-
sidered death from cardiovascular disease, which we defined as category 
390 to 459 in ICD-9 or category I in ICD-10, including index stroke.
4.5 Ethical considerations
Studies I-III were approved by the local ethics committee of Helsinki Univer-
sity Hospital (Dnro 73/13/03/00/11), and the follow-up of patients (Studies 
II-III) was approved by the National Institute of Health and Welfare (Dnro 
THL/956/5.05.00/2012). The inclusion of stroke-free control individuals 
for Study IV was also approved by the National Institute of Health and Wel-
fare. Informed consent was requested of each control subject, but not of the 
stroke patients.
4.6 Statistical analysis
For Study I, we constructed a multivariate model to explore which of the ECG 
parameters associated with HRCE. Binary logistic regression was adjusted 
for the confounders mentioned in Section 4.2. We tested each ECG parame-
ter in a separate regression model. We also performed principal component 
analysis of all ECG parameters in order to define the number of underlying 
uncorrelated components; 8 components were necessary to explain 95% of 
the overall variability in ECG parameters, and thus we used a factor of 8 in 
Bonferroni correction, setting the significance level at P<0.00625. We also 
calculated sensitivity, specificity, positive predictive value, and negative pre-
dictive value for the significant dichotomous parameters. Receiver operator 
characteristic (ROC) curves were made of the significant continuous pa-
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rameters, in order to calculate their area under the curve (AUC) to measure 
their predictive value. Since AF is a well-known explanatory factor for IS, we 
also tested the predictive value of the significant ECG parameters in a model 
from which patients known to suffer from AF were excluded.
In Studies II and III, we used Cox regression models with 95% CIs to inves-
tigate factors associated with the endpoints. First, using a univariate anal-
ysis, we determined   the significance of demographic factors, risk factors, 
and stroke characteristics for each endpoint, and used the factors with a 
significance level P<0.10 for further adjustment. A unique set of covariates 
was thus created for each endpoint. Then, we tested each ECG parameter in 
a separate multivariable model. Finally, we applied the Bonferroni correction 
factor of 8, based on the principal component analysis, to the P-values of 
ECG parameter analyses. We also presented our main results graphically, 
using Kaplan-Meier plots.
In Study II, we performed Uno’s C statistics to determine the added benefit 
to prognostic data upon clinical prognosticators. We also presented the re-
sults graphically by IDI plots. The C statistics model for each endpoint includ-
ed the clinical parameters that passed the significance selection process, all 
the continuous ECG parameters, and the binary ECG parameters that were 
not direct derivatives of any continuous parameter. Hence the ECG parame-
ters considered in the models were heart rate, P-wave duration, P-wave axis, 
PR-time, QRS duration, QRS axis, corrected QT-time, T-wave axis, QRS-T an-
gle, PTF, LVH indices, J-waves, T-wave inversions, and bundle branch blocks.
In Study IV, the strengths of association between markers of atrial ab-
normalities and IS occurrence were estimated by use of conditional logistic 
regression. Odds ratios and 95% CIs were calculated for the markers, and 
CI:s not straddling the value 1.00 were considered significant. A conditional 
logistic regression analysis was first performed on the whole population of 
IS patients and controls. Subgroup analyses were also performed on each 
etiologic subgroup, and controls were then only the corresponding control 
group. Each ECG variable was tested in a separate model, both in the anal-
ysis of the entire population, and in the subgroup analyses. Each subgroup 
analysis was adjusted for only those confounding factors found significant 
for the respective subgroups. 





5.1 Comorbidities and ECG findings in the study population
The ECG recording of IS patients used for data analysis was obtained a medi-
an of 2 days after IS (interquartile range 1-3 days). The most common comor-
bidities in our 690 IS-patient cohort for Studies I-III were dyslipidemia (60%), 
cigarette smoking (44%), and hypertension (38%); 12% had pre-existing car-
diovascular disease, 7.4% of our patients suffered IS due to LAA, 11.3% due to 
HRCE, 12.0% due to LRCE, 13.5% due to SVD, 16.8% due to dissections, 10.1% 
due to rare causes, the other 28.8% were cryptogenic.
Study IV utilized a slightly different subset of the HYSR. Descriptive data 
on their clinical variables of patients and controls are in Table 8. Of all subset 
patients, 6.5% suffered their stroke due to LAA, 9.0% due to HRCE, 14.8% 
due to SVD, 27.3% due to rare causes, 28.6% due to ESUS; 13.8% were cryp-
togenic but other than ESUS. The LRCE patients, and some in the crypto-
genic group from Studies I-III were placed in Study IV in the ESUS group. 
Nine cardioembolism patients suffered from AF. For more detailed data on 
cardioembolic sources, see Table 5.
The most common ECG abnormalities in our patients (Studies I-III) were 
T-wave inversions (16%), LVH (14%), prolonged P-waves (13%), and prolonged 
QTc (12%). AF was present in the ECG of 2.5%, and only one patient was in 
supraventricular tachycardia rhythm. PTF was present in 3.9%. Some major 
ECG abnormality appeared in 35%. Three patients had LBBB, ten had RBBB, 
nine had incomplete RBBB, and eight had left anterior fascicular block.
5.2 ECG and the etiology of young ischemic stroke
Most ECG abnormalities occurred in patients with etiology of HRCE, LAA, or 
SVD, and 65% of the HRCE patients had a major ECG abnormality; the corre-
sponding proportions in the LAA group was 45% and the SVD group 34%. 
After adjusting for confounders (see Methods), our logistic regression mod-
els showed an association with HRCE in these continuous ECG abnormalities: 
longer QRS duration, longer QTc, and wider QRS-T angle. Of the binary parame-
ters, PTF showed a strong association (hazard ratio 43.18 [95% CI10.28-181.38]). 
Lesser associations emerged in a wide QRS-T angle (9.11 [3.87-21.42]), T-wave 
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Table 5. High-risk sources of cardioembolism (n=51) in Study IV. Permission to reproduce granted under Taylor & 
Francis’ general terms.
Number of patients (%)
Continuous parameters OR (95% CI)
QRS duration, per ms 1.04 (1.02-1.06)
QTc (Bazett), per ms 1.02 (1.00-1.03)
QRS-T angle, per º 1.02 (1.01-1.03)
Dichotomized parameters
T-wave inversion 5.30 (2.67-10.55)
Prolonged QTc (Bazett) 3.89 (1.88-8.03)
P-terminal force (n = 27/672) 43.18 (10.28-181.38)









Table 6. ECG findings associated with HRCE. Adjusted for age, sex, hypertension, smoking, dyslipidemia, cardiovas-
cular disease, diabetes, obesity, NIHSS score, and lesion size and multiplicity. Permission to reproduce granted 











Table 7. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for HRCE of the 
significant binary ECG parameters. Permission to reproduce granted under Elsevier’s general terms.
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PTF had the highest specificity for HRCE, and T-wave inversion had the 
highest sensitivity (Table 7). The area under the ROC curve was 0.67 (0.60-
0.74) for QRS duration, 0.71 (0.64-0.78) for QTc and 0.78 (0.72-0.85) for 
QRS-T angle.
5.3 Recurrent events and their association to ECG
Of the 690 IS patients, 26.4% suffered some recurrent cardiovascular event, 
2.8% had more than one event during follow-up. 14.5% suffered a cardiac 
event and 14.6% a recurrent stroke (Table 8). Of the recurrent strokes, 87.1% 
were ischemic and 12.9% were hemorrhagic. Of the patients who suffered a 
recurrent stroke, 7.9% died because of it.
Multivariable Cox regression analyses of ECG parameters showed QRS 
duration, PTF, LVH by Cornell voltage-duration criteria, and bundle branch 
blocks all to be associated with the composite endpoint of any cardiovascu-
lar event, even after Bonferroni correction (Table 9).
ECG parameters associated with any cardiac events after IS were lon-
ger PR-time, longer QRS duration, longer QTc, prolonged P-wave, PTF, LVH 
by Cornell Voltage-Duration criteria, bundle branch blocks, and prolonged 
QRS duration, exceeding 110 ms (Table 10).
No ECG parameters were associated with stroke recurrence in multivar-
iate analysis.
After performing Uno’s C statistics analysis, we found no added prognos-
tic benefit for ECG parameters over clinical parameters for either stroke re-
currence, or cardiac events nor for cardiovascular event per se (Appendix 
Table 3).
5.4 Mortality and its association with ECG findings after young IS
Of our patients, 16.1% died during follow-up, with over half of these deaths due 
to cardiovascular causes; 15 patients (2.2% of the population) died during the 
first 30 days after IS. More details as to causes of death are in Table 11.
In adjusted analyses of ECG parameters’ association with all-cause mortal-
ity, the parameters significant after Bonferroni correction were higher heart 
rate, longer QTc, and shorter P-wave duration (Table 12). Only a higher heart 
rate was associated with death due to cardiovascular causes (Table 13).
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53
ICD-10 codes ICD-9 codes
Composite event*
Cardiovascular death
Hospitalization due to 
myocardial infarction or 
coronary artery disease
All mentioned in 
Methods
All mentioned in 
Methods, if fatal
I21-I25
All mentioned in 
Methods




Hospitalization due to atrial 
fibrillation
Hospitalization due 









Hospitalization due to other 
arrhythmias



















Table 8. Cardiovascular events during follow-up in the study population. Permission to reproduce granted under 
Taylor & Francis’ general terms.
* Any of the cardiovascular events mentioned below.
The association between mortality and shortness of P-wave was unusual, 
and we decided to investigate it further; after dichotomization at a threshold 
of 80 ms, we found 16 patients, of whom half died during follow-up, dying 
from various causes, only half from cardiovascular causes.
5.5 ECG differences between young IS patients and stroke-
free individuals
LVH, first-degree IAB, first-degree IAB combined with LVH, PTF, PTF com-
bined with LVH, abnormal P-wave, and abnormal P-wave combined with LVH 
were independently associated with HRCE (Table 14). LVH was associated 
with SVD, although only in univariate analysis (Appendix Table 4). First-de-
gree IAB and abnormal P-wave were also associated with non-ESUS crypto-
genic stroke subtype in multivariate analysis (Appendix Table 5).
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Continuous ECG parameters   HR* (95 % CI)
Heart rate, per 10/min






















QRS duration, per 10 ms
P-wave >120 ms










QTc, per 10 ms
LVH† (Sokolow-Lyon)




T-wave axis, per 10 degrees
LVH† (Cornell voltage)
Broad QRS (>110 ms)






















































Table 9. ECG parameters’ association with recurrent cardiovascular event after IS. Cox regression analyses adjusted 
for age, sex, obesity, hypertension, smoking, dyslipidemia, congestive heart failure, known atrial fibrillation (except 
for ECG rhythm), coronary artery disease, peripheral arterial disease, T1D and T2D, and stroke etiology. Corrected 
P-values indicate Bonferroni correction. Permission to reproduce granted under Taylor & Francis’ general terms.
Heart rate considered only for patients with sinus rhythm (n=672).
*Hazard ratio  |  †Left ventricular hypertrophy  |  ‡Atrial fibrillation
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Continuous ECG parameters   HR* (95 % CI)
Heart rate, per 10/min






















QRS duration, per 10 ms
P-wave >120 ms










QTc, per 10 ms
LVH† (Sokolow-Lyon)




T-wave axis, per 10 degrees
LVH† (Cornell voltage)
Broad QRS (>110 ms)






















































Table 10. Cox regression analyses showing ECG parameters’ association with cardiac events after IS, adjusted for 
confounders: age, sex, obesity, hypertension, smoking, congestive heart failure, known AF (except for ECG rhythm), 
coronary artery disease, peripheral arterial disease, T1D, T2D, and stroke etiology. Corrected P-values indicate Bon-
ferroni correction. Permission to reproduce granted under Taylor & Francis’ general terms.
Heart rate considered only for patients with sinus rhythm (n=672).
*Hazard ratio  |  †Left ventricular hypertrophy  |  ‡Atrial fibrillation
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Table 11. Causes of death in our IS population. Permission to reproduce granted under SAGE Publications’ general terms.








New ischemic or hemorrhagic stroke
Accident, suicide or poisoning
Cardiomyopathy
Complications of type 1 diabetes




Underlying cause of death other than cardiovascular




















*In addition to these, 8 patients had a cardiovascular intermediate or immediate cause of death; hence, 63 patients 
were in the cardiovascular death group.
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Table 12. ECG parameters’ relation to all-cause mortality. Cox regression analyses, adjusted for age, hypertension, 
smoking, type 1 diabetes, cardiovascular disease, known AF (except for rhythm), malignancy, heavy drinking, 
stroke etiology, NIHSS, and lesion size. Permission to reproduce granted under SAGE Publications’ general terms.
*Only considered for patients in sinus rhythm  |  AF, Atrial fibrillation  |  LVH, Left ventricular hypertrophy
Continuous ECG parameters   HR* (95 % CI)
Heart rate*, per 10/min










P-wave axis, per 10 degrees





PR-time, per 10 ms
P-terminal force
















QTc, per 10 ms





T-wave axis, per 10 degrees
Intraventricular conduction delay
Broad QRS >110 ms
























































Table 13. Association between ECG parameters and death due to cardiovascular causes. Cox regression adjusted 
for age, hypertension, type 2 diabetes, cardiovascular disease, known AF (except for rhythm), malignancy, heavy 
drinking, stroke etiology, NIHSS, and lesion size. Permission to reproduce granted under SAGE Publications’ 
general terms
*Only considered for patients in sinus rhythm  |  AF, Atrial fibrillation  |  LVH, Left ventricular hypertrophy
Continuous ECG parameters   HR* (95 % CI)
Heart rate*, per 10/min










P-wave axis, per 10 degrees





PR-time, per 10 ms
P-terminal force
















QTc, per 10 ms





T-wave axis, per 10 degrees
Intraventricular conduction delay
Broad QRS >110 ms
























































Table 14. Conditional logistic regression analysis of ECG abnormalities associated with cardioembolic stroke 
subtype (N=51). Model adjusted for diastolic blood pressure and HDL cholesterol. Controls for the HRCE patients 
are only those 87 defined as the control population for the HRCE patients. Permission to reproduce granted under 
Taylor & Francis’ general terms.
LVH regardless of other ECG findings
ECG abnormality
First-degree IAB
First-degree IAB and LVH
P-terminal force
P-terminal force and LVH
Abnormal P-wave












6.1 ECG findings in the study
Despite the young age of our study population, approximately one-third 
showed ECG abnormalities. Hindfelt’s material of young IS patients also 
showed ECG abnormalities in approximately one-third of their patients, 
although their specific ECG abnormalities differed somewhat. Although 
none of Hindfelt’s patients had AF, their prevalence of ST-T changes in 18% 
of patients, intraventricular conduction disturbances in 7% of patients, and 
signs of myocardial infarction in 2% were somewhat in line with our findings 
(Hindfelt & Nilsson 1976). Based on recent studies, paroxysmal AF may be 
underdiagnosed in our cohort, since ambulatory ECG was not widely used 
during the inclusion period (Dion et al. 2010, Šaňák et al.2015).
We had a large number of patients with PTF, compared to a population of 
healthy persons (Hiss & Lamb1962). Even a Finnish study on older individuals 
than ours showed singificantly less PTF than in our cohort (Eranti et al. 2014).
6.2 Utility of ECG in etiology prediction of young ischemic 
stroke
The HRCE group was the only one with a significant number of patients with 
PTF (26%). PTF had a high positive predictive value for HRCE, and should 
therefore raise a suspicion for this etiology, when found in a young IS patient. 
PTF indicates atrial enlargement or atrial stress, and also indicates elevat-
ed risk of IS (Miller et al. 1988, Soliman et al. 2010, Kamel et al. 2014). LVH, 
found in our cohort in 14%, and CHF in 6%, are probable causes of PTF; in 
patients with HRCE, these numbers were 24% and 50%. Heart failure was 
found in only 6% of patients in etiologic groups other than HRCE. AF also 
could, by the theory of atrial cardiopathy, be a mediating factor between 
PTF and HRCE, since both are known to associate with IS. No study has, 
to our knowledge, yet consistently shown the link between lower-grade PTF 
(0.004-0.006 mVs) and AF, although more severe PTF beneath 0.006 mVs 
has been linked to AF (Eranti et al. 2014).
The other ECG markers associated with HRCE (wide frontal QRS-T angle, 
T-wave inversions, and prolonged Qtc) also correlate with cardiac disease 
(Aro et al. 2012a, 2012b, Ishikawa et al. 2015).
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6.3 The relation of ECG findings to recurrent events after 
young ischemic stroke
It was not surprising that ECG abnormalities were best at predicting cardiac 
events, of all the various follow-up endpoints. We did, however, also expect 
some ECG abnormalities to be associated with recurrent stroke, since some 
ECG abnormalities are associated with suffering IS in the general population. 
These include LVH, prolonged QTc, PTF, premature ventricular complexes, 
and AF, which we did not find to be associated with stroke recurrence (Wolf 
et al. 1991, Ishikawa et al. 2009, Soliman et al. 2010, Agarwal et al. 2015, Ishi-
kawa et al. 2015, Kamel et al. 2015b).
One might also expect AF to be associated with recurrent cardiovascular 
events, since it is a major cause of morbidity and mortality in the general pop-
ulation (Wolf et al. 1978, Kannel et al. 1982). We did not, however, find such an 
association, and neither did an Italian study on young IS patients (Pezzini et 
al. 2014). One explanation may be the effectiveness of anticoagulant therapy 
initiated for virtually all IS patients with AF. Also a prolonged P-wave duration 
has been linked with IS in the general population, although we found no asso-
ciation with stroke recurrence (Ariyarajah et al. 2007). However, we did find 
a rather strong association between a prolonged P-wave and cardiac events. 
PTF was, as expected, associated with recurrent events, at a hazard ratio of 3, 
which is in line with its hazard ratio in the general population (Eranti et al. 2014). 
Bundle branch blocks were, as expected, associated with cardiovascu-
lar events after IS, although bundling LBBB and RBBB together, due to the 
small number of each, may lead to some ambiguity as to the relevance of 
each, especially when the prognostic relevance of RBBB is not quite clear 
even in the general population (Bussink et al. 2013, Eriksson et al. 2005).
LVH was, as expected, associated with recurrent cardiovascular events 
and cardiac events, with a point estimate of approximately two, resembling 
that of the general population, and as also expected, Cornell voltage-dura-
tion criteria had a higher predictive value than Sokolow-Lyon or Cornell volt-
age criteria (Rautaharju & Soliman 2014). An increased risk of cardiovascu-
lar or cardiac events in patients with a wider QRS complex was predictable, 
because it has been linked to adverse events also in the general population 
(Desai et al. 2006, Aro et al. 2011, Kurl et al. 2012).
A prolonged QTc was associated with cardiac events, as it is in the gen-
eral population, although its association with suffering (recurrent) IS did not 
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emerge in our population (Wong et al. 2003, Ishikawa et al. 2015). 
6.4 Relationships of clinical and ECG findings to mortality 
after young ischemic stroke
Our finding of a higher heart rate as associated with higher mortaliy is in 
line with the findings of Erdur and colleagues (2014) on older IS patients, 
although we studied the heart rate in the subacute phase and Erdur in the 
acute phase. Many theories exist on why a higher heart rate is associated 
with poorer prognosis, since this is a finding in many populations other than 
IS patients. Theories include increased psychological stress, increased sym-
pathetic tone, lack of physical exercise, increased shear stress on arterial 
walls, and reduced angiogenesis (Custodis et al. 2010). We have no better 
explanation regarding the specific mechanism than these findings.
We found longer QTc to be associated with higher mortality, although 
quite surprisingly not with cardiovascular mortaliy, although in other popula-
tions, a longer QTc indeed has been more strongly linked to cardiovascular 
mortality (Wong et al. 2003, Noseworthy et al. 2012, Ishikawa et al. 2015).
Our only P-wave marker associated with increased mortality was a short 
P-wave <80 ms, although the causes of death in those patients were incon-
sistent, and this might be a type I error.
We find it interesting that no other ECG abnormalities were associated 
with mortality, since the association is strong in many other populations, and 
pathological Q-waves are associated with higher mortality even in IS pa-
tients of higher age (Candelise et al. 1991, Kaarisalo et al. 1997, Tanaka et 
al. 2004, Eriksson et al. 2005, Ohsawa et al. 2007, Aro et al. 2011, Aro et al. 
2012a, 2012b, Bussink et al. 2013, Eranti et al. 2014, Ishikawa et al. 2014). We 
did, however, find in our population quite heterogeneous causes of death, 
which may explain the weak association with ECG parameters.
A quite peculiar finding involving clinical parameters and mortality is that 
T1D was associated with only all-cause mortality, whereas T2D was associat-
ed only with cardiovascular mortality, although in a general population, both 
types are strongly associated with both types of mortality (Soedamah-Muthu 
et al. 2006, Allemann 2009, Tancredi et al. 2015). One explanation is that T2D in 
young age is a more aggressive disease than in old age; hence, cardiovascular 
complications and mortality occur early, accentuating cardiovascular causes 
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of death (Hillier & Pedula 2003). In our specific and rather small population, this 
result is not, however, generalizable and needs further research. Moreover, 
the nonexistent association between T2D and all-cause mortality and T1D and 
cardiovascular mortality may be type II errors.
6.5 ECG differences between young ischemic stroke pa-
tients and healthy individuals
In recent years, the role of AF as a risk factor for cardioembolic stroke has 
expanded from arrhythmia that causes stasis and thrombus formation in the 
left atrial appendage, to indicating fibrous atrial cardiopathy. In fibrous atrial 
cardiopathy, the fibrosis disrupts atrial electrical conduction properties, pre-
disposing to re-entry and proliferation of ectopic foci promoting AF, whereas 
inflammation, endothelial dysfunction, and atrial hypocontractility promote 
thrombus formation (Hirsh et al. 2015, Kamel et al. 2016).
We found the P-wave abnormalities IAB and PTF associated with IS, and 
specifically with HRCE. Stroke is probably not the cause of PTF per se, our IS 
patients were already hospitalized, and therefore possible cases of cardiac de-
compensation leading to PTF in an acute setting were probably already under 
treatment. Both prolonged P-wave duration and PTF have been associated 
with increased risk of developing AF, which may be a mediating factor between 
P-wave abnormalities and IS (Agarwal et al. 2003, Eranti et al. 2014). However, 
PTF and third-degree IAB have also been linked to IS, even when adjusting the 
models for AF, and therefore a fibrous atrial cardiopathy may also be linked to 
atrial embolic IS without AF (Kamel et al. 2014, O’Neal et al. 2016). We found, 
as expected, PTF and first-degree IAB to be associated specifically with HRCE 
subtype, although our cases with third-degree IAB were too few for analysis.
Although PTF and increased P wave duration are markers of atrial patholo-
gy, these findings are quite common in healthy individuals; we therefore tried 
combining the atrial markers with LVH, in a search for higher predictive val-
ues (Soliman et al. 2013, Eranti et al. 2014). A pathologic P-wave elevates IS 
risk in a population of solely LVH patients (Kohsaka et al. 2005). Pathophysi-
ologically, atrial abnormality on ECG, indicating left atrial pressure overload, 
can also be viewed as a marker of dysfunction of the left ventricle, reflecting 
more severe heart disease than does isolated LVH (Tanoue et al. 2017). Al-
though we found higher point estimates for IS and the HRCE subtype in pa-
64
DISCUSSION
tients both with atrial abnormalities and with LVH, the confidence intervals 
were wide and no certain association strengthening occurred, compared to 
the situation with atrial abnormality or LVH alone (Table 14). SVD is strongly 
associated with diabetes, and T2D is also a risk factor for LVH, independent 
of hypertension (De Jong et al. 2017). We also found diabetes as significant-
ly correlating with LVH, and the higher amount of diabetes type 2 in the SVD 
subgroup may explain LVH is associated with SVD (Appendix Table 6).
Of special interest would be whether the ESUS or the cryptogenic stroke 
subgroup would share similar ECG abnormalities as the cardioembolism 
subgroup, and thus suggest a common pathogenesis of stroke in these 
groups; we did find an association between first-degree IAB and non-ESUS 
cryptogenic stroke, and also between P-wave abnormalities and non-ESUS 
cryptogenic stroke (Appendix Table 5). The theory of fibrous atrial cardiopa-
thy described here is receiving more evidence, and cryptogenic strokes may, 
at least some of them, be undetected cardioembolic strokes.
6.6 Strengths and limitations
Our study has both strengths and limitations. Strengths include our popu-
lations being quite large, our good clinical data, and our ability to cope well 
with confounders. Our ECG analysis involved a wide range of parameters, 
and was based on standardized criteria. We received our follow-up data from 
reliable registers, and our follow-up time was quite long. We also managed to 
recruit a large number of age-, sex-, and ethnicity-matched control subjects.
Limitations include an almost exclusively northern European population, 
which reduces our results’ generalizability. Our subset included only 70% of 
our original cohort, which may cause selection bias. Some of our patients may 
have shown acute-phase changes on their analyzed ECG, but some not, since 
our time-window for inclusion was rather wide. Some ECG abnormalities and 
endpoints were quite scarce, resulting in wide confidence intervals. Some end-
points were also quite unspecific, representing many disease mechanisms. In 
Study IV, the main limitation was the time difference in enrollment of the case- 
and control cohorts. Since blood pressure levels may differ between eras, 
namely be higher in the control population during their era, and therefore the 
prevalence of LVH could be overestimated in the control population. The lack 
of echocardiography data can also be considered a limitation, although there 
is also value in what ECG can tell, regardless of echocardiographic findings.
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7 CONCLUSIONS AND FUTURE DIRECTIONS
Certain ECG parameters are specifically associated with HRCE subtype 
of IS. A young IS patient with PTF is likely to have suffered a stroke due to 
HRCE. Other ECG abnormalities pointing towards HRCE include T-wave in-
versions, prolonged QTc, and a wide QRS-T angle.
Bundle branch blocks, PTF, a broad QRS complex, prolonged P-wave 
duration, a leftward P-wave axis, and LVH according to Cornell voltage du-
ration criteria are associated with future cardiac and cardiovascular events 
after IS in young persons. These findings did not, however, show any added 
benefit over that of clinical parameters, when analyzed with C statistics. We 
found no ECG parameters to be associated with stroke recurrence.
A higher heart rate during the subacute phase of stroke is associated with 
both higher all-cause mortality and cardiovascular mortality. Longer QTc is 
associated with higher all-cause mortality.
We found PTF and first-degree IAB to be more common in young adult IS 
patients than in stroke-free control subjects. In subgroup analysis, this as-
sociation applied only to the HRCE and non-ESUS cryptogenic subtypes, 
and these subtypes explain why P-wave abnormalities are associated with 
IS. LVH also showed an association with HRCE and SVD.
Current research in stroke cardiology seems to focus on ESUS and atri-
al cardiopathy. Future directions should be even earlier detection of cardio-
embolic stroke risk, with electrocardiography and imaging modalities, and 
clarification of when antithrombotic medication for patients showing signs of 
atrial cardiopathy will be beneficial before and after IS. The ongoing ESUS 
trials with anticoagulant medication may find more IS patients potential-
ly improving in prognosis after IS. However, a risk exists of treating ESUS 
patients as a homogenous group, which they certainly are not, and hence 
research on stratification of ESUS patients is also essential. The prognostic 
power of ECG markers in IS patients is still inconclusive and larger prospec-
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Hypertension treatment or a history of hypertension: systolic blood 
pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg 
Age in years at the time of stroke
Male or female
Dyslipidemia medication, or: total cholesterol level ≥5.0 mmol/L, 
low-density lipoprotein level ≥3.0 mmol/L, or high-density 
lipoprotein level <1.0 mmol/L
Fasting plasma glucose >7.0 mmol/L, no insulin dependence
Ejection fraction <55%
Clinical diagnosis
Atrial fibrillation diagnosed on ECG either in association with 
stroke, or previously
Malignancy diagnosed within the year prior to stroke, or 
previously but not in remission 
Fasting plasma glucose >7.0 mmol/L, insulin dependence
Alcohol intake >200 g per week
Definition
Appendix Table 1. Definitions of the clinical parameters used only in studies I-III.






Systolic blood pressure on admission 
or 24 h after admission; mean of both 
when available






Diastolic blood pressure on admission 
or 24 h after admission; mean of both 
when available
Smoking at least one cigarette per day 
within one year before the stroke
Fasting plasma glucose ≥7.0 mmol/l 
(126 mg/dL) or plasma glucose after 
ingestion of 75 g oral glucose ≥11.1 
mmol/l (200 mg/dL), with or without 




Blood sample 24-72 hours after 
admission
Coronary artery disease diagnosed 
before the stroke;  previous 
myocardial infarction, or a positive 
result in diagnostic methods such 
as perfusion imaging, coronary 
angiography or exercise ECG
Mean of systolic blood pressure 
measured after 5 minutes of rest 
and 1½ minutes after the first 
measurement
Body mass index ≥30 kg/m2
Mean of diastolic blood pressure 
measured after 5 minutes of rest 
and 1½ minutes after the first 
measurement
Smoking cigars, pipe or at least 
one cigarette every or almost every 
day within one year before the 
comprehensive clinical examination 
including ECG
Diagnosis of either type 1 or type 2 
diabetes at the time of evaluation; only 
fasting glucose was measured from all 
participants
Blood sample at health examination
Diagnosis of coronary artery disease 
at the time of evaluation;  previous 
myocardial infarction, or a positive 
result in diagnostic methods such 
as perfusion imaging, coronary 
angiography or exercise ECG
Controls
Appendix Table 2. Definitions of the clinical parameters for cases and controls (Study IV). Permission to reproduce 
granted under Taylor & Francis’ general terms
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Appendix Table 3. Data on Uno’s C statistics for predictive models of cardiovascular event, cardiac event and recur-
rent stroke (Study II). Models with clinical predictors, clinical predictors with ECG predictors, and their differences 
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Appendix Table 4. Univariate conditional logistic regression analysis on the ECG abnormalities associated with 
stroke subtypes (Study IV). Numbers are odds ratio in comparison to controls and 95 % confidence interval. 
Permission to reproduce granted under Taylor & Francis’ general terms.
ECG 
abnormality
LAAN=37 CEN=51 SVDN=84 Rare  causes 
N=155
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ECG 
abnormality
LAAN=37 SVDN=84 Rare  causes 
N=155




















































































Appendix Table 5. ECG abnormality differences between controls and cases of different stroke etiologies apart 
from CE. Each patient group was adjusted for the parameters found associated with stroke in univariate analysis 
(P<0.10). LAA was adjusted for smoking, systolic blood pressure, diabetes and HDL cholesterol. SVD was adjusted 
for smoking, systolic blood pressure, obesity, coronary artery disease and HDL cholesterol. Etiology of rare causes 
was adjusted for systolic blood pressure, diastolic blood pressure, diabetes and HDL cholesterol. ESUS was ad-
justed for smoking, diastolic blood pressure and HDL cholesterol. Cryptogenic stroke was adjusted for smoking, di-
astolic blood pressure, diabetes and HDL cholesterol (Study IV). Numbers are odds ratio in comparison to controls 
and 95 % confidence interval. Permission to reproduce granted under Taylor & Francis’ general terms.
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Sex* -0.21 -0.15 -0.12 n.s. -0.06 -0.18 -0.14 -0.07 n.s.
LVH 1° IAB 1°IAB & 
LVH







3°IAB 3°IAB & 
LVH








n.s. n.s. 0.06 0.10 0.05 0.07 0.08 0.09 0.07
Diabetes 0.06 n.s. 0.05 0.09 0.11 n.s. 0.07 n.s. 0.08





0.26 0.12 0.20 0.27 0.24 0.17 0.25 0.08 0.15
CHA2DS2-
VASc score




0.19 0.16 0.16 0.06 0.10 0.18 0.18 0.10 0.11
Smoking n.s. n.s. -0.05 n.s. n.s. n.s. -0.06 n.s. -0.05
Obesity -0.05 0.07 n.s. 0.06 n.s. 0.12 n.s. 0.10 n.s.
*Positive correlation indicates correlation with female gender
Appendix Table 6. Pearson correlations between clinical parameters and ECG findings. P-values >0.05 are consid-
ered not significant (n.s.). The CHADS2 and CHA2DS2-VASc scores are calculated from stroke patients data only, 
since vascular disease and congestive heart failure were not well documented in control subjects (Study IV). 
Permission to reproduce granted under Taylor & Francis’ general terms.
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